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Treatment and management of heart disease is challenging due to the heart’s 
limited ability to self-repair. Although current approaches to manage heart disease, such 
as pharmacotherapy, medical devices, lifestyle changes, and heart transplantation, have 
improved and extended the quality of life for millions of individuals, they have inherent 
shortcomings. Future strategies to manage heart disease will likely be based upon a 
combination of biological and engineering approaches through cell therapy and tissue 
engineering strategies, both of which have the potential to regenerate the myocardium 
and improve cardiac function. However, a key hurdle in applying biological approaches 
is our limited ability to produce reliable tissue to study disease progression and tissue 
development, therapeutic intervention, drug discovery, or tissue replacement. 
Establishing hallmarks of the native myocardium in engineered cardiac tissue is a central 
goal and appears to be required for creating functional tissue that can serve as a surrogate 
for in vitro testing or the eventual replacement of diseased or injured myocardium. The 
objective of this research was to apply an engineering approach to develop tools and 
methods to produce engineered cardiac tissue and characterize both native and 
engineered cardiac tissue. Three phases of research included: 1) the development and 
utilization of a framework to characterize microstructure in living cardiac tissue using 
confocal microscopy and local dye delivery, 2) the development a next-generation 
bioreactor capable of continuously monitoring force-displacement in engineered tissue, 
iv 
and 3) the application of confocal imaging and image analysis to quantitatively describe 
features of the native myocardium, focusing on myocyte geometry and spatial 
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Heart disease is the number one cause of death in developed countries, accounting 
for more than 600,000 deaths annually in the United States alone with estimated direct 
and indirect costs of over $475 billion in 2009 [1]. These high costs place a heavy burden 
on our society and there are more than 800,000 new cases of myocardial infarction and 
550,000 new cases of congestive heart failure diagnosed annually in the United States 
[1]. Due to the heart’s limited capacity to self-repair and restore pump function following 
injury, treatment and management of heart disease is challenging, especially if diagnosed 
in late stages.  
Current methods for clinical diagnosis, such as magnetic resonance imaging 
(MRI), computed tomography (CT), ultrasound, endoscopy, and fluoroscopy do not 
provide real-time cellular-level information on structure and function, which may be 
essential towards early detection [2]. Current approaches to manage heart disease include 
pharmaceutical drugs, medical devices, lifestyle changes, and surgical interventions such 
as heart transplantation [3]. Although these approaches have improved and extended the 
quality of life for millions of individuals, they have inherent shortcomings. 
Pharmacotherapy can delay, but not necessarily reverse, the natural course of heart 
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disease [4]. Commonly, medical devices are only palliative and plagued by 
biocompatibility and hemocompatibility issues. Organ transplants, the end-stage solution 
to heart failure, are in short supply for the estimated 6 million individuals living with 
congestive heart failure and nearly 8 million individuals affected by myocardial 
infarction [1].  
Future strategies to manage and treat heart disease will likely be based upon 
biological approaches using cell therapy and tissue engineering strategies, both of which 
have the potential to regenerate the myocardium and improve cardiac function. A key 
hurdle in applying biological approaches is our limited ability to produce realistic tissue 
to study disease progression and tissue development, therapeutic intervention, drug 
discovery, or tissue replacement. Although the field of tissue engineering has moved 
beyond static two-dimensional (2D) surfaces towards three-dimensional (3D) 
environments which resemble the in vivo space, many shortcomings remain [5]. Some of 
these shortcomings are related to the need for advanced tissue culture platforms that can 
control environmental conditions such as mechanical, electrical and chemical factors. 
Furthermore, there is a need for measurement and analysis techniques to characterize 
structure and function in both engineered and native tissue. Establishing hallmarks of the 
native myocardium in engineered tissue appears essential for creating functional tissue 
that can serve as a surrogate for in vitro testing or the eventual replacement of diseased or 
injured myocardium [6]. Measurement and analysis techniques that provide 3D 
descriptions of tissue structure will allow for more realistic definition of native tissue 
which can serve as specifications for engineered tissue.  
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The overarching objective of this research was to apply an engineering approach to 
develop tools and methods to produce engineered cardiac tissue and characterize both 
native and engineered cardiac tissue. The objective was addressed through three phases 
of research:  
1) Develop and utilize a framework to characterize microstructure in living cardiac 
tissue using confocal microscopy and local dye delivery. 
2) Develop a next-generation bioreactor capable of continuously monitoring force-
displacement in engineered tissue. 
3) Apply confocal imaging and image analysis to quantitatively describe features of 
the native myocardium, focusing on myocyte geometry and spatial distribution of 
a major gap junction protein connexin-43 (Cx43), in both engineered tissue and 
native tissue. 
Before describing the work in these research phases, background on cardiac tissue 
structure and function, heart disease, key approaches in cell therapy and tissue 
engineering, current state-of-the-art bioreactors and confocal microscopy are reviewed.  
1.2 Cardiac Tissue Structure and Function 
The heart is a highly metabolically active organ that beats an astonishing 2.5 
billion times in an average lifespan. The mammalian heart is comprised of four chambers: 
two atria, which primarily serve as reservoirs for venous return and two ventricles which 
pump blood out of the heart (Fig. 1.1a). In many cases of heart disease, the myocardium 
of the left ventricle is compromised, which results in reduced pump function. The left 





Figure 1.1 – Cardiac structure. (a) Cross-section showing four chambers of the heart. (b) 
Staining of postnatal day 12 left ventricular cardiac tissue of rat with α-sarcomeric actinin 
(green) to identify Z-discs of myocytes and vimentin (red) to identify non-myocytes (e.g. 
fibroblasts). (c) Zoomed region from B showing sarcomeres which are defined from Z-
disc to Z-disc. (d, e) postnatal day 12 (d) and adult (e) left ventricular cardiac tissue of rat 
stained with wheat germ agglutinin (green) to identify cell borders and Cx43 (red) to 
identify gap junctions. Myocytes appear dark with Cx43 plaques located on the lateral 




extracellular matrix (ECM) and cells, including myocytes, fibroblasts, endothelial, and 
vascular smooth muscle cells. Although myocytes only account for 20-40% of the cell 
population they occupy approximately 80-90% of the tissue volume [7, 8]. Fibroblasts 
account for the majority of cells in the heart and are in close spatial proximity to 
myocytes as shown in Fig. 1.1b. 
Myocytes comprise sarcomeres, which are the fundamental unit of contraction 
and defined as multimolecular complexes between neighboring Z-discs (Fig. 1.1c). Z-
discs are anchoring sites for actin and have a regular arrangement and spacing in healthy 
myocardium. Contraction of sarcomeres can be explained by the sliding filament theory 
based on myosin binding to actin in the presence of calcium and subsequent 
conformational changes of the myosin. Calcium concentration changes in the cytoplasm 
of myocytes can be described through a process known as calcium-induced calcium 
release (CICR) during excitation-contraction (EC) coupling. EC coupling is the process 
of converting an electrical stimulus (i.e., action potential) into a mechanical response. 
When a myocyte is depolarized, calcium ions enter the cytoplasm from the extracellular 
space through sarcolemmal ion channels. Cytoplasmic calcium binds to ryanodine 
receptors on the sarcoplasmic reticulum, which causes a further increase in the 
cytoplasmic calcium concentration. This process is known as CICR.   
The left ventricular myocardium remodels during development and in response to 
environmental stress and disease [9, 10]. The remodeling is complex and can involve 
alterations in cell geometry, protein expression and distribution, and the extracellular 
matrix [9]. Remodeling can be a normal physiologic process due to development, 
exercise, and pregnancy or pathologic in response to hypertension, myocardial injury, and 
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ventricular unloading. Myocytes have been shown to increase in length, width, area and 
volume by 9%, 28%, 39% and 78%, respectively during hypertrophic remodeling [11], 
and decrease in volume by 50-75% with little change in length during atrophy [12]. 
Furthermore, early stages of ischemia are known to decrease the extracellular resistance 
and increase conduction velocity, which is indicative of reduced interstitial space [13]. 
Myocytes form a 3D syncytium by coupling via gap junction channels, which 
allows rapid propagation of electrical signals between cells and synchronous contraction. 
Cx43, the predominant gap junction channel isoform in ventricular myocytes [14, 15], 
has a half-life of approximately 2 hours [16, 17] and undergoes significant changes in 
density and distribution during development and disease [14, 18-23]. For example, in left 
ventricular neonatal rat cardiac tissue Cx43 clusters are lateralized as they are found to be 
distributed over the lateral sarcolemma of myocytes as shown in Fig. 1.1d. As the heart 
matures, Cx43 becomes polarized and organized at the cell ends after approximately 90 
days postbirth as showed in Fig. 1.1e [18]. Gap junction channels also remodel due to 
disease in the adult heart. For example, as human cardiac hypertrophy progresses into 
heart failure Cx43 expression decreases and the distribution of Cx43 changes from being 
polarized to lateralized [9, 14, 19]. Gap junction channels can be coerced to rearrange in 
vitro. A recent study in 2D monolayers of neonatal rat myocytes indicated polarization of 
Cx43 localization by mechanical stretching [24]. The functional importance and dynamic 
nature of Cx43 makes it a target for analysis in both native and engineered cardiac tissue. 
However, most analyses are based on quantifying expression levels through Western 
blots or producing qualitative descriptions from 2D images in both native [15, 18, 19, 21, 
25-27] and engineered tissues [28-32]. The complex spatial arrangement and 
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rearrangement may be better described and understood by quantitative 3D analysis 
techniques.    
Fibroblasts account for the majority of nonmyocyte cells in the heart. Recent 
studies revealed the importance of fibroblasts in normal cardiac function [33, 34]. In 
addition to maintaining the ECM, fibroblasts are involved in paracrine signaling [34] and 
cell-cell communication between myocytes and other fibroblasts [35]. They are a main 
contributor to tissue remodeling in many forms of myocardial disease [34]. Following 
injury, such as infarction, fibroblasts secrete extracellular matrix to replace diseased 
myocardium with stiff, fibrotic tissue that leads to deleterious effects on cardiac function 
[36]. This deposition of collagen not only occurs in the infarcted region, but in the 
surrounding regions as well. The importance of fibroblasts is also becoming apparent in 
cardiac tissue engineering. In a study using co-cultures of myocytes and fibroblasts, 
myocyte elongation, alignment, and viability was shown to depend on the presence of 
fibroblasts [37].  
The numerous structural and functional changes that occur during development 
and disease demonstrate a need to understand the complex structure-function 
relationships in cardiac tissue. This understanding may provide insights into onset, 
progression, prevention and therapy of heart disease. 
1.3 Heart Disease 
Although the heart is considered an engineering marvel by nature with complex 
structure and function, it is prone to fail beyond repair [5]. Heart disease is a general term 
used to categorize a variety of pathologies that adversely affect the heart. Coronary heart 
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disease is the most common form and accounts for more than two-thirds of heart related 
deaths in the United States [1]. Oftentimes, coronary heart disease can lead to myocardial 
infarction, which occurs due to lack of blood supply to the heart most commonly caused 
by blockage of the coronary artery. The lack of blood supply during myocardial 
infarction initiates a wound healing response that involves inflammation, myocyte death 
and formation of a collagen scar [38, 39]. Loss of myocardium not only occurs in the 
infracted region but the surrounding regions of the left ventricle as well. This loss causes 
an increase in mechanical stress on the left ventricle, triggering a biochemical cascade of 
intracellular signaling, which modulates a structural and functional remodeling process 
[39]. Myocytes are replaced by fibroblasts which deposit collagen to form a scar. The 
mechanical properties of the scar tissue counterbalance the distending forces on the left 
ventricular wall. This loss of contractile tissue deteriorates pump function, reduces stroke 
volume and can lead to congestive heart failure.   
Congestive heart failure, defined as the inability of the heart to supply sufficient 
blood flow to the body, is not only caused by myocardial infarction, but can also be 
caused by hypertension, valvular diseases and other cardiomyopathies such as dilated and 
hypertrophic cardiomyopathy [40]. The many forms of heart disease are not mutually 
exclusive, and often patients have one or more forms of cardiovascular disease [1]. 
Another form of heart disease is congenital heart defects which occur in 9 of every 1000 
births and are the leading cause of death in the first year of life [1]. Congenital heart 
defects are commonly ventricular septal defects, atrial septal defects, valvular pulmonary 
stenosis, or other malformations [1, 41]. These defects often require reconstructive 
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surgery and in cases of severe malformation, surgical reconstruction is not sufficient to 
sustain life [41].  
Treatment and management of heart disease is challenging due to the limited 
capacity of the heart to repair following injury. Although current strategies such as 
pharmaceutical drugs, medical devices and lifestyle changes have improved and extended 
the life for millions of individuals, they are commonly targeted to managing heart disease 
as opposed to treatment [3]. Although organ transplants are successful in treating end-
stage heart failure, they are in short supply [1]. Future strategies to manage and treat heart 
disease will likely be based upon biological approaches using cell therapy and tissue 
engineering strategies, both of which have the potential to regenerate the myocardium 
and improve cardiac function.  
1.4 Biological Approaches to Treat Heart Disease  
Biological strategies for treatment of heart disease can be categorized into cell 
therapy and tissue engineering approaches. Cardiac cell therapy, also known as in situ 
cardiomyoplasty, is based on introducing progenitor or stem cells into the myocardium to 
treat infarction and congestive heart failure and has been in the clinical arena since early 
2000 [42, 43]. Tissue engineering approaches to treat heart disease are much further from 
clinical evaluation and are based on either in vitro cultivation of cells with or without 
biomaterials and subsequent implantation or in situ approaches which combine cells with 
injectable biomaterials [44]. However, tissue engineering not only aims to provide organ 
replacement. Cardiac tissue produced in vitro can serve as a surrogate for testing 
pharmaceutics and understanding cardiovascular physiology, pathophysiology and 
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developmental processes [45-47]. In fact, the original definition of tissue engineering 
established at a conference by the National Science Foundation in Lake Tahoe, 1988 
reflects this concept [48]: “tissue engineering is the application of principles and methods 
of engineering and life sciences toward fundamental understanding of structure-function 
relationships in normal and pathological mammalian tissues and the development of 
biological substitutes to restore, maintain, or improve tissue function.” The following 
sections discuss the current status of cell therapy and tissue engineering.   
1.4.1 Cell Therapy 
Cardiac cell therapy is based on introducing progenitor or stem cells into the 
myocardium to treat acute and chronic heart failure [42, 43]. The benefits of cell therapy 
are controversial and the majority of studies only show a modest improvement in patient 
outcomes [43, 49]. When clinical trials first began in early 2000, the central dogma was 
that the delivered cells would exhibit or acquire in situ phenotypic features of myocytes 
and thus replace the irreversibly lost myocytes [42]. However, most of the favorable 
outcomes have been attributed to paracrine effects of the donor cells and angiogenesis as 
opposed to myogenesis [42]. Cytokines and growth factors released by the donor cells 
induce protective signaling pathways in the host myocardium to promote angiogenesis, 
reduce apoptosis, encourage favorable matrix remodeling and in some cases coerce 
resident native cells to differentiate into myocytes [50, 51]. The hypothesis that paracrine 
signaling is responsible for the improvement in cardiac function is supported by a recent 
study which demonstrated that injection of mesenchymal stem cell conditioned media 
had equivalent effects to injected cells [52].  
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Several types of progenitor and stem cells have been applied in human clinical 
trials including: skeletal myoblast, circulating progenitor cells, CD133-positive cells, 
CD34-positive cells, endothelial progenitor cells and bone marrow derived cells such as 
mononuclear cells, hematopoietic stem cells and mesenchymal stem cells [49, 53]. Early 
clinical trials started with skeletal myoblasts because of their favorable results in animal 
studies [43]. Although skeletal myoblasts do not differentiate directly into cardiac 
myocytes, they differentiate into myotubes which are resistant to ischemic environments 
[54, 55]. Furthermore, they offer a favorable immune response due to their autologous 
origin and have a restricted lineage which provides a safety factor against tumorogenesis. 
However, incidence of cardiac arrhythmias in patients with skeletal myoblasts injections 
has raised concern [56]. Since skeletal myoblasts and myotubes do not express Cx43, 
they do not integrate electrically with the host myocardium and consequently beat 
asynchronously [57].  
Embryonic stem cells are the classical stem cells and hold the potential to self 
renew and differentiate into any cell type. However, they have not been applied clinically 
due to their potential to form teratomas and induce an immune response due to their 
allogenic origin [58, 59]. More recently, induced pluripotent stem cells have been 
developed from human origin and resemble many features of embryonic stem cells [60, 
61]. Although induced pluripotent stem cells have successfully been differentiated into 
cardiac myocytes [62], their potential application to human cardiac cell therapy is still in 
its infancy as reprogramming efficiency is low and costly [63]. 
A major shortcoming with cell therapy is poor cell retention and engraftment [64].  
Less than 10% of the donor cells are retained in the myocardium within 24 hours of 
12 
 
delivery [63, 65, 66]. Ultimately, donor cells are injected into an unfavorable, hostile 
environment that does not support cell survival. Methods to successfully increase 
retention and engraftment have been implemented such as preconditioning cells with 
pharmaceutical agents, introducing prosurvival cocktails and delivering cells within 
hydrogels which polymerize in situ [64, 67]. However, cell retention and engraftment are 
still unfavorable. In addition, a general consensus in the field of cell therapy is the lack of 
a mechanistic understanding on how donor cells improve cardiac function and patient 
outcomes [53, 54, 68].  
1.4.2 Cardiac Tissue Engineering 
Traditionally, cardiac tissue engineering is perceived as an approach for 
replacement or repair of diseased or injured myocardium. However, there are a variety of 
alternative applications for in vitro cardiac tissue engineering, including applications in 
pharmaceutics that require high throughput techniques for drug screening and safety 
testing [45, 46], physiological genomics [69], and cardiovascular physiology to 
understand disease and developmental processes [47]. Studying cardiac tissue in vitro 
requires tissue culture platforms that allow for control over environmental conditions to 
direct cells into healthy and diseased tissue and analytical tools for understanding 
structure and function.  
A central goal in cardiac tissue engineering is to establish the 3D architecture of 
native tissue. Although 2D culture has been utilized to successfully probe at many 
scientific questions, 3D tissue samples provide a more realistic environment. Three-
dimensional tissue constructs more closely mimic the cellular microenvironment, which 
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has profound effects on the properties, behavior and functions of resident cells [6, 70, 
71]. Capturing this microenvironment through 3D tissue samples may provide a more 
realistic test sample that can better predict in vivo results. However, replicating the 3D 
structure and function of cardiac tissue in vitro is challenging due to the inherent 
complexity of cardiac tissue. Compounding this complexity is the dynamic nature of 
cardiac tissue. As pointed out above, remodeling of structural properties, such as myocyte 
geometry and protein distributions, occurs during development and disease. Therefore, 
choosing an appropriate native target for tissue engineering is not trivial and requires 
careful selection based on requirements.  
Several approaches have been applied to establish 3D tissue samples, each with 
some level of success. The current state-of-the-art for developing cardiac tissue in vitro 
can be categorized into four techniques: 1) seeding scaffold materials with cells, 2) 
entrapping cells in a 3D environment, 3) creating cell sheets, and 4) decellularizing and 
recellularizing tissue [41]. Scaffolding materials can serve as a substrate to direct cell 
proliferation and differentiation and are usually porous and fibrous to allow for cell 
seeding and diffusion. Degradable synthetic scaffolds, such as polyglyocolic acid [72, 73] 
and polyglycerol sebacate [32], and natural scaffolds, such as collagen foam sponges 
[28], alginate [74] and gelatin [75], have been used to engineer cardiac tissue. Synthetic 
materials have the advantage of engineering control, but are limited in their 
biocompatibility in vivo. Natural materials can provide signaling to cells through surface 
receptors, but are often limited in their ability to be engineered for a specific purpose.  
The formation of 3D spontaneously contracting cardiac constructs has been 
created by entrapping cardiac cells in a hydrogel comprised of Matrigel (extracellular 
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matrix from Engelbreth-Holm-Swarm tumors), collagen [76], and more recently 
fibrinogen [77]. This encapsulation approach is arguably the most successful for creating 
densely packed and highly aligned myocytes as found in native tissue. The addition of 
mechanical stimulation can improve structural organization and increase force of 
contraction [78-80]. Cells entrapped in collagen/Matrigel mixtures have been shown to 
electrically and mechanically couple with the host myocardium in rats [81, 82] and 
improve cardiac function following infarction [83]. More recently, fibrin-based samples 
have been fabricated using either neonatal cardiac cells [77] or human embryonic stem 
cells [84]. These fibrin-based samples are cultured in a multiwell plate format and 
proposed to serve as models to study pharmaceutical agents and probe at physiological 
processes.     
Cell sheet cardiac tissue engineering is a scaffold-free approach to tissue 
engineering and utilizes a temperature-sensitive poly(N-isopropylacrylamide) (PIPAAm) 
coated surface seeded with cells [85]. During culture at 37°C PIPAAm is hydrophobic, as 
the temperature is lowered below its lower critical solution temperature (LCST) of 32°C 
the polymer becomes hydrophilic to release a monolayer of cells. The cell sheets 
spontaneously contract and can be stacked to form 3D engineered constructs which are 
electrically coupled [85]. This approach allows for cells to detach without disrupting gap 
junctions and other surface proteins that are destroyed during enzymatic digestion. To 
overcome limitations of the construct thickness “polysurgery” has been performed on 
rats, which involves repeated implantation of sheets comprised of three cell layers [86]. 
Although this approach requires repeated access to the surgical site, up to 10 sheets (each 
three layers thick) have been implanted and shown to become vascularized and 
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electrically couple with the host myocardium [86]. Moreover, the cell sheet approach in 
an infracted rat model resulted in a much higher survival rate and improvement in cardiac 
function over direct cell injection techniques [87].  
The recellularization approach relies on decellularizing harvested organs and 
tissues to remove immunogenic substances and repopulating with cells to form tissue 
[88]. The composition, architecture and mechanical properties of the decellularized ECM 
are preserved by this process. This approach has been applied to adult rat hearts, which 
were reseeded with intramural injections of neonatal cardiac cells and after 8 days of 
cultivation were able to generate pressures at approximately 2% of the adult heart [89]. 
Although this is an appealing approach, complete reseeding and functionality of a native 
heart has not been demonstrated.   
Many of the developed in vitro approaches rely on bioreactors to control 
environmental conditions and characterize the engineered tissue. A bioreactor can be 
defined as an apparatus that attempts to mimic and reproduce physiological conditions in 
order to grow and maintain biological cells or tissues [90]. Bioreactors are an attractive 
option to provide 3D tissue culture environments to allow for cell-cell and cell-matrix 
interactions. Current bioreactors for cardiac tissue engineering can be categorized based 
on their design [91, 92].  
Spinner-flask bioreactors overcome mass transfer limitations of static culture 
environments and have shown to improve cell seeding and development of cardiac tissue 
constructs [73, 93]. Similarly, rotating wall vessels are capable of producing low levels of 
shear stress while improving mass transfer rates, and have demonstrated the ability to 
create elongated myocytes, establish intracellular communication, and form 
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spontaneously contracting cardiac tissue constructs [29, 72, 94, 95]. Direct perfusion 
systems have overcome limitations of poor cell infiltration and nonuniform cell coverage 
in 3D tissue constructs and have been shown to enhance cell survival, growth, and 
function [93, 96-98]. Environmental features of bioreactors for cardiac tissue engineering 
include mechanical conditioning such as cyclic strain [78-80, 99] and electrical 
stimulation [28, 99-102]. Mechanical conditioning was found to enhance cell 
proliferation and matrix organization of human heart cells [103], and structural 
organization and force of contraction in neonatal rat cardiac constructs [78-80, 104-106]. 
Electrical stimulation was shown to induce myocyte alignment, increase electrical 
coupling via Cx43 up-regulation, and increase conduction velocity [28, 107]. However, 
only little is known about the specific mechanical force and pacing regime that is 
responsible for promoting development to a specific tissue phenotype [91, 108].    
Although several approaches have been used to engineer cardiac tissue with some 
level of success, many shortcomings remain [5]. Some of these shortcomings are related 
to the need for advanced tissue culture platforms that can control environmental 
conditions such as mechanical, electrical and chemical factors and integrate analysis 
techniques to continuously characterize the response of cells to environmental stimuli. 
Moreover, current bioreactors are often unique designs used in a series of targeted 
studies. Although they meet their intended function there is no emerging standard [5]. 
Many of these designs are limited in function, complex, unreliable and difficult to set up 
and operate [91, 109]. They have not been designed for low cost, ease of use, and 
reliability. Furthermore, current bioreactors for cardiac tissue engineering are not 
outfitted for analysis of engineered tissue during culture. Characterizing tissue samples 
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during development can provide feedback without destroying tissue samples. A 
bioreactor that is designed with common cell culture equipment, off the shelf 
components, and reproducible parts to address these limitations and includes cyclic 
stretching and tools for nondestructive analyses, such as force measurement and confocal 
imaging capabilities, would be desirable. 
In addition, a central goal in cardiac tissue engineering is to establish hallmarks of 
the native myocardium. Applying an engineering approach to meet this goal requires a set 
of requirements and specifications. The engineering paradigm relies on specifications, 
which are derived directly from a set of requirements. When applying the engineering 
paradigm to the field of tissue engineering, specifications for the target tissue would 
logically be derived from native tissue. However, few studies apply the same analysis 
techniques used to characterize their engineered tissue to native cardiac tissue for 
comparison purposes. Ideally, native tissue samples would be characterized to establish 
quantitative specifications for engineered cardiac tissue.  
Evaluation of engineered cardiac tissue structure and function is commonly 
constrained to endpoint analyses [110, 111]. Most analyses of structure are based on 2D 
images from light microscopy, confocal microscopy, scanning electron microscopy and 
transmission electron microscopy [112]. The 2D images provide information on the 
expression and distribution of troponin I and myosin heavy chain for presence and 
maintenance of the cardiac phenotype [28, 37]; α-actin for cell alignment [28, 37, 113]; 
Cx43 [28, 114] and β-integrin [28] for determining cell-cell and cell-matrix 
communication, respectively; cell nuclei for cell density [37, 114]; and live/dead assays 
for cell viability [114]. Real-time polymermerase chain reaction (RT-PCR) and Western 
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blot techniques have been used to quantify the gene and protein expression, respectively, 
of α-actin, α-myosin heavy chain (MHC), β-MHC, Cx43, and β-integrin [28]. However, 
an outstanding goal in cardiac tissue engineering is to establish structural hallmarks of the 
native myocardium. The native myocardium exhibits a complex 3D architecture where 
analysis techniques which allow for 3D characterization would be beneficial. 
1.5 Confocal Microscopy and Image Processing 
Confocal imaging is one technique that has the capability of producing high 
resolution 3D images. Recent advances in imaging technologies combined with new 
developments in fluorescent markers [115, 116] have established microscopic imaging as 
a major research tool to measure structure and function of cells and tissues [117-122]. 
Unlike traditional microscopic imaging modalities, such as bright field microscopy, 
confocal laser scanning microscopy (CLSM) has the ability to distinguish in-focus from 
out-of-focus light [123]. The concept of confocal microscopy was pioneered by Marvin 
Minsky in 1955 when he was trying to overcome limitations of bright field microscopy 
[124]. Minsky found that by illuminating and collecting light from a single point avoided 
the scattered light found to obscure bright field images. Fig. 1.2a demonstrates the 
principle of confocal microscopy. A point source of light is focused on a specimen 
through an objective (blue lines in Fig. 1.2a). Emitted light is collected from only the 
point source by passing through a pinhole (blue lines in Fig. 1.2a). Light that is not 
emitted from the focal point is excluded (red dashed lines in Fig. 1.2a).  
This ability to reject out-of-focus light allows CLSM to control the depth of field 





Figure 1.2 – Confocal microscopy. (a) Schematic demonstrating principle of confocal 




[125]. Images are acquired point-by-point (i.e., pixel-by-pixel) by rastering a laser over 
an image plane. Sequential optical sections can be stacked to create a 3D image volume 
where pixels become volumetric elements known as voxels (Fig. 1.2b). These advantages 
have established CLSM as a major research technique used to gain insights into cellular 
and molecular physiology and pathophysiology.  
In addition to producing high resolution images of fixed tissue samples, CLSM is 
particularly well suited for providing real-time, noninvasive data on sub-cellular and 
cellular processes of living tissue [110]. Living tissue can be probed with structural or 
functional markers and imaged on conventional upright or inverted confocal microscopes 
or the recently developed fiber-optics based confocal imaging systems [126-131]. Fiber-
optics based confocal imaging systems consist of an objective placed at the end of a 3 
meter long, thin optical fiber. This portable technology allows for in situ and in vivo 
imaging in human patients and laboratory animal testing. However, since confocal 
imaging relies on fluorescence and most tissues do not exhibit significant 
autofluorescence, a fluorescent marker must be present in the imaged region. There are 
currently few, if any, techniques to apply dye directly to the imaged area of living tissue 
in a controlled and efficient manner.       
Images from confocal microscopy suffer from various imaging artifacts. These 
artifacts are caused by several factors such as heterogeneous refractive indices within the 
specimen, mismatches in the refractive index of the specimen, objective, glass slide and 
the material between those, and chromatic and spherical aberrations introduced by the 
optical elements in the microscope [125]. The resulting scattering, absorption and 
refraction of light degrade image quality, for instance, signal-to-noise ratio and image 
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resolution. An approach to characterize imaging artifacts is to measure the response of 
the confocal imaging system to a point source of light, yielding the so-called point spread 
function (PSF). The PSF describes how the confocal imaging system responds to a point 
source of light. PSFs are measured by imaging objects of a known size, commonly 
fluorescent beads [125, 132, 133]. Fig. 1.3 shows an example of a measured PSF from a 
confocal imaging system (Zeiss LSM 5, Jena, Germany) using a 40x oil immersion lens 
with a numerical aperture of 1.3 and 543 nm laser line for excitation. Fluorescent beads 
with a 100 nm diameter were imaged at a 100 nm isometric resolution. Although the 
beads are similar in size as a single voxel, the resultant images portray the beads to be 
larger than a single voxel (Figs. 1.3a and c), in particular, parallel to the laser beam 
direction. The effective resolution of the confocal microscope can be estimated from the 
PSF. The full width at half maximum (FWHM) intensity of the PSF describes the 
minimum size in which an object can be spatially resolved [134]. As shown in Figs. 1.3b 
and d the FWHM are two to three times larger in the direction of the laser beam 
compared to the FWHM in the image plane. 
Image quality can be improved based on the measured PSFs. The response g of an 
imaging system to given sources can be described by convolution of the source image f 
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Deconvolution algorithms, such as the iterative Richardson-Lucy algorithm [135], can be 





Figure 1.3 – Example of a measured PSF. (a, c) Central cross-section through 3D image 
stack from 100 nm fluorescent beads imaged at 100 nm resolution in the plane 
perpendicular to laser beam direction (a) and parallel to laser beam direction (c). (b, d) 




















with the cross-correlation operator ⊗ and g0 ≡ g.  
Three-dimensional confocal microscopy is based on acquiring sequential serial 
2D images of the specimen. Acquiring sequential optical sections from thick specimens 
results in lower signal intensity at increased depths. Several factors are responsible for 
depth-dependent attenuation such as absorption and scattering of excitation and emission 
light, photobleaching, and uneven fluorescent labeling. Regardless of the cause, decay in 
signal intensity can be estimated empirically by fitting an exponential function of the 
form:  
 
      
    
 
where Iz is the intensity, I0 is intensity at slice 0, a is the attenuation coefficient estimating 
intensity loss, and z is the image depth [136-139]. Applying a slice-wise correction factor 
to 3D image data is essential when applying thresholding to segment objects within the 
image stacks. Commonly, segmentation is based on thresholding and in order to have a 
constant threshold value through the 3D image volume, images acquired at deeper depths 
must be corrected [132, 138, 140, 141].  
 Three-dimensional reconstructions of cardiac structure can be obtained from 3D 
confocal image data using segmentation and thresholding approaches [117, 118, 121, 
142]. For example, the structure of transverse tubules which are invaginations in the 
sarcolemma of myocytes, [121] and the collagenous microstructure of ventricular 
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trabeculae carneae [142] have been described using 3D reconstructions from confocal 
image data. These 3D reconstructions can serve as a basis for performing quantitative 
measures to describe cellular and subcellular features. Establishing a cohesive framework 
that includes methods for labeling tissue, image processing and extracting quantitative 
features from both living and fixed cardiac tissue specimens will help direct our 
understanding in order to engineer and specify cultured tissue.  
1.6 Introduction to this Dissertation 
In this work, an engineering approach was applied to develop and utilize tools and 
methods to produce engineered cardiac tissue, characterize both native and engineered 
cardiac tissue and test the hypothesis that the structure of age-matched native cardiac 
tissue serves as a representative control for engineered cardiac tissue. Establishing 
hallmarks of the native myocardium in engineered cardiac tissue is a central goal and 
appears to be required for creating functional tissue that can serve as a surrogate for in 
vitro testing or the eventual replacement of diseased or injured myocardium [6]. We 
worked towards this longstanding goal by developing and applying confocal imaging 
techniques and analyses to characterize the 3D architecture of native and engineered 
cardiac tissue. In addition, we engineered and developed specialized cultureware to meet 
the needs of our studies. This type of customized cultureware is essential for controlling 
environmental conditions, integrating analysis techniques to characterize tissue during 
development and directing cells into functional tissue [5]. Three phases of research were 
conducted to address unmet needs in the field of cardiac tissue engineering. 
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In Chapter 2, a confocal microscopy based framework was developed and utilized 
to characterize the microstructure in living cardiac tissue. Previous studies have applied 
confocal microscopy ex vivo to characterize normal and pathological alterations in 
cardiac microstructure for analysis and modeling purposes [21, 118-120, 143]. However, 
most of these studies were performed using fixed tissue and time consuming 
immunochemistry procedures which require excision, fixation, sectioning and cell 
membrane perforation [112]. Our developed framework includes a method for local dye 
delivery to living cardiac tissue, confocal microscopy techniques and image processing 
tools for the 3D analysis of myocyte geometry and the extracellular space. In living tissue 
preparations we demonstrated that our hydrogel-based dye delivery method provided dye 
in sufficient concentration to obtain images with both standard and fiber-optics based 
confocal imaging systems. Image processing and myocyte segmentation was applied to 
extract individual myocytes from 3D image data. The developed framework for image 
processing and analysis served as a foundation for the research performed in Chapter 4. 
An important perspective of the developed imaging approach and analysis is the future 
application to diagnosis and patient-specific modeling of cardiac tissue structure.  
In Chapter 3, a bioreactor capable of continuously monitoring force-displacement 
in engineered tissue was developed. Although other laboratory bioreactors meet their 
intended function, they are typically developed to meet the needs of a single laboratory 
and targeted towards a specific series of experiments. Bioreactors that are reproducible, 
modifiable and easy to use have the potential to be adopted by multiple laboratories and 
become a type of open-source design platform for tissue engineering. Toward this end, 
our bioreactor was designed with common cell culture equipment and off the shelf and 
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easily reproducible components. A full bill of materials and associated engineering 
drawings are available for our bioreactor. A novelty of the developed bioreactor is in the 
ability to nondestructively characterize tissue samples during development. Forces from 
inside the bioreactor are translated to an external transducer through a magnet-diaphragm 
assembly, which allows for characterization of mechanical properties of the tissue 
samples during culture. Bench top testing and tissue culture experiments were performed 
to validate bioreactor performance. The ability to characterize passive and active forces 
in engineered tissue is important for high throughput monitoring techniques in 
pharmaceutical testing [45, 46] and cardiac tissue engineering [78, 99]. Our ability to 
quickly design and implement custom bioreactors was key to the work described in 
Chapters 3 and 4. This capability comes at a low cost and high value due to using 
standard off the shelf cultureware as starting material. 
In Chapter 4, approaches for confocal imaging and image analysis were 
developed and applied to quantitatively describe features of the native myocardium, 
focusing on myocyte geometry and spatial distribution of a major gap junction protein 
Cx43, in both engineered tissue and native tissue. A central goal in cardiac tissue 
engineering is to establish structural features of the native myocardium. As described in 
Chapter 1, native tissue is complex and structurally remodels during development and 
disease. Therefore, choosing an appropriate native target for tissue engineering is not 
trivial and requires careful selection based on requirements. Moreover, many studies 
describe structural features qualitatively from 2D images. In our study, we quantitatively 
compared engineered cardiac tissue with and without electrical stimulation to both age-
matched and adult native myocardium using 3D confocal imaging. We addressed the 
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hypothesis that the application of environmental cues directs engineered tissue towards a 
phenotype resembling that of age-matched native myocardium. The results of the study 
support this hypothesis and reveal that electrical stimulation produces tissue with 
myocyte geometries and the spatial distributions of Cx43 which more closely resemble 
age-matched native myocardium as opposed to mature adult tissue.  
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A Novel Approach for Dye Delivery
and Tissue Characterization
Richard A. Lasher, Robert W. Hitchcock, and Frank B. Sachse*, Member, IEEE
Abstract—This work presents a methodology for modeling
of cardiac tissue micro-structure. The approach is based on
catheter-based confocal imaging systems, which are emerging as
tools for diagnosis in various clinical disciplines. A limitation of
these systems is that a ﬂuorescent marker must be available in
sufﬁcient concentration in the imaged region. We introduce a novel
method for the local delivery of ﬂuorescent markers to cardiac
tissue based on a hydro-gel carrier brought into contact with the
tissue surface. The method was tested with living rabbit cardiac
tissue and applied to acquire three-dimensional image stacks with
a standard inverted confocal microscope and two-dimensional
images with a catheter-based confocal microscope. We processed
these image stacks to obtain spatial models and quantitative data
on tissue microstructure. Volumes of atrial and ventricular my-
ocytes were   and  	 m  
 ,
respectively. Atrial and ventricular myocyte volume fractions were
     % and    % 
 , respectively.
Atrial and ventricular myocyte density was  	 and
	 	 cells/mm  
 , respectively. These
statistical data and spatial descriptions of tissue microstructure
provide important input for modeling studies of cardiac tissue
function. We propose that the described methodology can also be
used to characterize diseased tissue and allows for personalized
modeling of cardiac tissue.
Index Terms—Biomedical image processing, cardiac tissue, con-
focal microscopy, ﬂuorescent labeling, patient-speciﬁc modeling.
I. INTRODUCTION
A DVANCES in scanning confocal microscopy combinedwith new developments in ﬂuorescent markers have
made it possible to image structure and function of living cells
and tissue [1], [2]. Scanning confocal microscopy is based on
optical sectioning and ﬂuorescence, and has several advantages
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over traditional microscopic imaging modalities [3]. In par-
ticular, confocal microscopy features the ability to control the
depth of ﬁeld, reject out-of-focus light, and collect sequential
optical sections from thick specimens [4]. These advantages
have established confocal microscopy as a major research
technique used to gain insights into cell and tissue physiology
and pathophysiology. Furthermore, image data obtained from
confocal microscopy enables spatial modeling of cells and
tissues [5]–[7]. Recently, catheter-based confocal microscopic
systems have been developed, which allow for in vivo imaging
[8]–[11]. In principle, these systems allow microscopic imaging
inside living subjects. Hence, these systems have been proposed
for clinical applications, in particular for diagnosis of human
diseases [8]–[11].
This work is focused on confocal microscopic imaging of car-
diac tissue, its spatial modeling, and quantitative analysis. Car-
diac tissue can be viewed as a composite material comprised
of ﬂuids and cells, including myocytes, ﬁbroblasts, endothelial,
vascular smooth muscle, and neuronal cells. Myocytes occupy
most of the volume in cardiac tissue and are responsible for car-
diac contraction. The (interstitial) space between cardiac cells
is ﬁlled with ﬂuid and an interconnected extracellular matrix
comprised mostly of collagen and capillary vessels [12], [13].
Quantity, density, and morphology of cardiac cells vary signif-
icantly during development, amongst species, for each cardiac
tissue and in heart disease [14]–[16]. Many diseases, such as
hypertrophy, atrophy, infarction, and ischemia, are known to be
associated with alterations in cell geometry and density. For in-
stance, in cardiac hypertrophy, human epicardial left ventricular
myocytes have been shown to increase in length, width, area,
and volume by approximately 9%, 28%, 39%, and 78%, re-
spectively, and rabbit right ventricular myocytes are known to
increase in length and width by approximately 7.5% and 36%,
respectively [17]. In atrophic hearts, left ventricular myocytes
decrease in volume by 50%–75%, with little change in my-
ocyte length [18]. Cardiac diseases are also known to alter the
extracellular environment. Following myocardial infarction, ﬁ-
brosis (excessive deposition of extracellular matrix mediated
by ﬁbroblasts) occurs not only in the infarcted region, but in
the surrounding regions as well [19]. Furthermore, early stages
of ischemia are known to decrease the extracellular resistance,
which is indicative of reduced interstitial space [20]. A more
comprehensive understanding of these pathologic cellular and
tissue alterations could allow the recently developed catheter-
0278-0062/$26.00 © 2009 IEEE
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based confocal systems and optical imaging techniques to pro-
vide a new set of diagnostic tools in cardiology.
In previous studies, pathologic alterations of cardiac mi-
crostructure have been characterized ex vivo with confocal
microscopy [6], [7], [21], [22]. In principle, the recently devel-
oped catheter-based confocal imaging systems enable similar
studies to be performed in vivo. However, the application of
confocal microscopy requires that ﬂuorescent dye for labeling
of proteins or structures is available in sufﬁcient concentra-
tion in the region of interest. Dye delivery is commonly a
time-consuming immunochemistry procedure, requiring exci-
sion, ﬁxation, and sectioning of tissue as well as cell membrane
disruption [23]. In particular, in vivo dye delivery is an un-
resolved issue that impedes the application of catheter-based
confocal imaging in these studies.
Image data from both living and ﬁxed tissue specimens have
been used to develop models that describe physical and physio-
logical properties of cardiac tissue. For instance, models that de-
scribe mechanical and electrophysiological properties in normal
and diseased cells and tissues have been developed [24], [25].
Most of these models do not directly account for the detailed
tissuemicrostructure, but describe tissue properties with lumped
parameters or homogenization approaches [24], [26]. A small
number of models have been introduced, which are based on an
analytical description of microstructure [27] or on two-dimen-
sional microscopic images [5], [21].
In this study, we describe an approach for modeling and
analyzing cardiac tissue with confocal microscopy. The ap-
proach is characterized with studies on living cardiac tissue
from rabbits; speciﬁcally, dissected right ventricular papillary
muscle, subepicardial ventricular and atrial tissue. We intro-
duce a novel method for ﬂuorescent dye delivery, which allows
for acquisition of three-dimensional stacks of confocal images
of living cardiac tissue. These image stacks are processed to
remove background signals and correct for depth-dependent
attenuation. Furthermore, image stacks are deconvolved and
processed to yield detailed spatial models and quantitative
data on cardiac microstructure. Our quantitative values on
myocyte geometry are compared with literature values. In
addition, we characterized the method for local dye delivery
with a catheter-based confocal system and a living rabbit heart
preparation. We propose that the described methodology can be
used for personalized modeling of cardiac tissue microstructure
and diagnosis based on catheter-based confocal microscopy.
II. MATERIALS AND METHODS
A. Tissue Section Preparation
All experiments were approved by the Institutional Animal
Care and Use Committee (IACUC) at the University of Utah.
Adult rabbits were anesthetized with pentobarbital (30 mg/kg)
and anticoagulated with heparin (2500 USP units/kg). Fol-
lowing thoracotomy hearts were quickly excised and placed in
a modiﬁed oxygenated Tyrode’s solution (in mM: 126 NaCl,
11 Dextrose, 0.1 CaCl , 13.2 KCl, 1 MgCl , 12.9 NaOH,
24 HEPES) at room temperature. The hearts were dissected
into tissue sections of three types: right ventricular papillary
Fig. 1. Experimental setup for confocal imaging of cardiac tissue.
muscle ( mm 1 mm 5 mm), subepicardial ventricular
( mm 2 mm) and atrial tissue ( mm 2 mm). The
sections were secured to a polycarbonate holder with sutures as
shown in Fig. 1 and stored in the solution until imaging.
B. Image Acquisition
Images were obtained within 6 h of heart isolation. Tissue
sections were covered by oxygenated Tyrode’s solution during
the imaging (Fig. 1). Tissue sections were imaged on an
8-bit BioRad MRC-1024 laser-scanning confocal microscope
(BioRad, Hercules, CA) with a 40x oil-immersion objective
lens (Nikon, Tokyo, Japan). Three-dimensional image stacks
with a spatial resolution of 200 200 200 nm were obtained
with a ﬁeld-of–view of 204.8 153.6 m extending
up to 80 m into the myocardium ( direction). The -axis
was parallel to the laser beam direction.
C. Dye Delivery
Thin hydrogel slices (4 mm 4 mm 40 m thick) were cre-
ated using 6.5% agar (GenePure LE Agarose, ISC BioExpress,
Kaysville, UT) in water. These slices were placed in solutions
of ﬂuorescent dyes and the dye was allowed to diffuse into
the agar hydrogel. Dextran-conjugated, lysine-ﬁxable Texas
Red with a molecular weight of 3 kDa and excitation/emission
wavelengths of 595/615 nm was used at concentrations of
6–12 mg/mL (Molecular Probes, Eugene, OR). This dye and
other dextran-conjugated dyes allow for speciﬁc labeling of
the extracellular space [28], [29]. An imaging chamber was
created by cutting an aperture from the bottom of a polystyrene
weighing dish and gluing a size #0 glass slide over the opening.
The dye-loaded hydrogel slice was placed on the glass slide and
dye was delivered by gently pressing the tissue onto the slide.
Precautions were taken to ensure that the tissue sample was not
compressed in the imaged region. We selected image regions
with a distance of at least 10 m between the glass slide and
tissue surface. Images were acquired by imaging through the
glass slide and hydrogel (Fig. 1).
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Fig. 2. Schematic of experimental and processing methods.
D. Measurement of Point Spread Functions and Deconvolution
Image stacks were deconvolved with the iterative
Richardson–Lucy algorithm using a measured point spread
function (PSF) as previously described [30]. Brieﬂy, the
response of an imaging system to given sources can be
described by convolution of the source image with the point
spread function
(1)
The iterative Richardson–Lucy algorithm was used to recon-
struct the source image
(2)
with the cross-correlation operator and . The three-di-
mensional PSF was characterized by imaging 100-nm ﬂuores-
cent beads embedded in agar. Images of 15 beads were ex-
tracted, aligned and averaged to obtain the PSF, which allowed
us to quantitatively characterize our imaging approach. Finally,
the PSF was ﬁltered by applying an average ﬁlter and resampled
with a resolution of 200 nm 200 nm 200 nm. The PSF was
applied to deconvolve the image stacks.
E. Image Processing, Segmentation and Geometric Analysis
Signal-to-noise ratios in the raw images were estimated to
characterize image stacks. Regions of 300 voxels were sampled
inside myocytes to calculate variances of signal intensity and in
the extracellular space to calculate mean signal intensity. The
signal-to-noise ratio was calculated from the mean signal inten-
sity divided by the variance.
Raw image stacks were processed using a combination of
C++ and MatLab software (MathWorks, Natick,MA) to remove
background signals and correct for depth-dependent attenuation
(Fig. 2). The background signal was estimated by averaging sig-
nals in small regions where the expected intensity is zero (i.e.,
inside myocytes). Depth-dependent attenuation of signal inten-
sity was calculated by selecting lines in the -axis (laser beam)
direction with the smallest standard deviation of the associated
intensity. Intensities along these lines were ﬁt to an exponential
function using least square optimization to obtain a slice-wise
scaling factor as a function of depth.
Myocytes were segmented by manually deforming a surface
mesh [31] followed by iterative thresholding. An initially el-
lipsoid-shaped mesh comprised of 5120 triangles was wrapped
around each myocyte in the ﬁeld of interest (Fig. 6). Histograms
of voxel intensities were created for the volume enclosed by
each mesh to calculate the mode and standard deviation of
voxel intensities. Threshold values were chosen independently
for each myocyte based on the calculated mode and standard
deviation to distinguish between intramyocyte and extracellular
spaces.
After thresholding, geometric analysis was performed on the
extracted whole myocytes. Principal component analysis (PCA)
was used to determine the principal axis of each segmented
myocyte [32]. A bounding box was created around each my-
ocyte based on the PCA as illustrated in Fig. 6(d). The bounding
box dimensions in direction of the ﬁrst, second, and third prin-
cipal axis were considered to be the myocyte length, width,
and height, respectively. Myocyte volume was calculated by
counting the intramyocyte voxels. Average cross-sectional area
was determined by dividing cell volume by length. The volume
fraction of tissue occupied bymyocytes was determined by sam-
pling random volumes of 300 300 30 voxels within regions
of the image stack where all myocytes were segmented. My-
ocyte density was deﬁned as mean of the myocyte volume frac-
tion (MVF) divided by the volume of each cell
(3)
F. Catheter-Based Confocal Imaging of Heart Preparations
For some imaging studies, excised hearts were mounted
and perfused with the modiﬁed Tyrode’s solution (above) at
8 mL/min retrogradely through the aorta using the Langendorff
method [33]. Two-dimensional images with a ﬁeld-of-view of
176.3 124.9 m and a lateral resolution of 0.48 m were ac-
quired from the Langendorff preparation with a catheter-based
confocal system (FCM1000, Leica, Wetzlar, Germany) and a
microprobe (M/30). The microprobe tip diameter was 4.2 mm
and the working distance was 30 m. A hydrogel dye carrier
was conﬁgured as an agar sheath that ﬁt over the catheter tip,
as shown in Fig. 3(a).
III. RESULTS
A. Dye Delivery and Image Acquisition
We characterized our approach for dye delivery and image
acquisition in experimental studies with living cardiac tissue of
various types. Upon gently pressing the tissue sections onto the
hydrogel carrier, the dextran-conjugated Texas Red dye diffused
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Fig. 3. Imaging with catheter-based confocal microscopy system (Leica FCM
1000). (a) M/30 confocal microprobe with hydrogel carrier loaded with dye. (b)
Image of atrial tissue acquired with catheter-based confocal microscopy system
and the modiﬁed microprobe. Scale: 5 mm in (a) and 50  m in (b).
Fig. 4. Exemplary raw XY images from a three-dimensional stack of atrial
tissue. The images are from the (a) epicardial surface and a depth of (b) 10  m,
(c) 20  m, and (d) 30  m into the myocardium. Scale: 50  m in (a) applies to
(a)–(d).
rapidly through the endo- or epicardial layers and into the my-
ocardium. The dye was immediately available in sufﬁcient con-
centration for confocal imaging of the cardiac microstructure.
Exemplary two-dimensional images of atrial and ventricular
tissue sections acquired with the BioRad confocal microscope
are shown in Figs. 4 and 5, respectively. These images orig-
inate from three-dimensional stacks covering approximately
1 m outside of the tissue surface and up to 80 m into the
myocardium. Fluorescence appeared to be associated with
clefts between cells (interstitial space), collagen ﬁbers, trans-
verse tubules and capillary vessels; whereas darker regions
appeared to be associated with cells. Image slices through the
epicardial and endocardial network of thin collagen ﬁbers in
atrial and ventricular tissue are shown in Fig. 4(a) and Fig. 5(a),
respectively. The ﬁbers are brighter than their surroundings
and appear to be, to some degree, orientated parallel to the
myocytes. The image through the ventricular endocardium
[Fig. 5(a)] includes endothelial cells. Image slices into atrial
and ventricular myocardium are presented in Fig. 4(b)–(d) and
Fig. 5(b)–(d), respectively. These image slices are from depths
of 10, 20, and 30 m into the myocardium with respect to the
epicardial or endocardial surface layer [Fig. 4(a) and Fig. 5(a)].
The density of the network of collagen ﬁbers appeared to be
larger in the endo- and epicardium than within the myocardium.
Furthermore, images extending further into the myocardium
exhibited less overall ﬂuorescence.
Optical properties of the BioRad confocal microscopy system
were characterized by measurement of PSFs as described above.
The PSF exhibited full widths at half maximum of 0.30 m in
the XY plane (transverse to the laser-beam) and 1.85 m in the
direction (parallel to the laser beam).
We also acquired two-dimensional images with a catheter-
based confocal microscope (FCM1000, Leica Microsystems,
Wetzlar, Germany). The dye carrier was attached to the catheter
tip and gently pressed on the epicardial surface of the atria and
ventricles of a Langendorff-perfused heart. An exemplary two-
dimensional image of atrial tissue is shown in Fig. 3(b). As in
our studies of tissue sections with the BioRad confocal micro-
scope, the dye was immediately available for imaging. High and
low ﬂuorescence intensities were associated with the extra- and
intracellular spaces, respectively.
B. Image Quantiﬁcation and Modeling of Tissue
We applied methods of digital image processing and analysis
to quantitatively describe and model cardiac tissue microstruc-
ture from three-dimensional image data. For this purpose, we
acquired 19 image stacks from a total of nine rabbits for sub-
sequent analysis. Fourteen of these stacks were rejected from
analysis due to low signal-to-noise ratios, discontinuities within
the image stack by motion and/or poor tissue quality. Signal-to-
noise ratios below 3 were considered low. We removed back-
ground signals, corrected for depth-dependent attenuation, and
deconvolved the image stacks as described. Fig. 5(e) and (f) il-
lustrates the effect of this processing on the image stacks. Pro-
cessed image stacks exhibit ﬁne details of myocytes such as
the transverse tubular system [Fig. 5(f)], which were difﬁcult
to identify in the unprocessed image data [Fig. 5(e)].
Individual myocytes were segmented from three-dimensional
image stacks (Fig. 6), which allowed for subsequent spatial
modeling (Figs. 7 and 8) and quantitative analysis of myocytes
(Tables I and II). Segmentation was performed on 50 atrial
myocytes and 36 ventricular myocytes. Quantitative analysis
was only performed on whole myocytes, which included 28
atrial myocytes and 20 ventricular myocytes.
An exemplary segmentation of a single myocyte from a
three-dimensional stack of atrial tissue is shown in Fig. 6. The
manually deformed surface mesh is illustrated in three orthog-
onal planes in Fig. 6(a)–(c). Threshold values to distinguish
between intramyocyte and extracellular space were chosen to
be the mode plus two standard deviations of signal intensity
for each segmented myocyte. Fig. 6(d) shows the segmented
myocyte after thresholding and in a bounding box aligned to the
principal axes of the myocyte. The dimensions of the bounding
box determined the length, width and height of the myocyte.
Three-dimensional spatial models of segmented myocytes
from three-dimensional stacks of atrial and ventricular tissue
are shown in Figs. 7 and 8, respectively. Fig. 7(d) shows a
three-dimensional visualization of the atrial model overlaid
with orthogonal confocal images.
Quantitative analysis revealed mean and standard deviation
of lengths, widths and heights of atrial myocytes
to be , and m, respec-
tively, and ventricular myocytes to be
, and m, respectively (Table I). Average vol-
umes of atrial and ventricular myocytes were and
m , respectively. Furthermore, the myocyte
volume fractions for atrial and ventricular tissue were
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Fig. 5. Exemplary raw XY images from a three-dimensional stack of ventricular tissue. The images are from the (a) endocardial surface and a depth of (b) 10  m,
(c) 20  m, and (d) 30  m into the myocardium. (e) Zoomed view of region marked by white box in (c). (f) Processed image from region marked by white box in
(c). White arrows indicate cross-sections of transverse tubules. Scale: 50  m in (a) applies to (a)–(d), 2  m in (e) applies also to (f).
Fig. 6. Exemplary segmentation of a single cardiac myocyte in (a) XY, (b) XZ,
and (c) YZ images of atrial tissue. (d) Three-dimensional model of myocyte cre-
ated by manual segmentation and thresholding. Scale: 20  m applies to (a)–(c).
Fig. 7. Three-dimensional model of atrial tissue shown (a) from epicardial sur-
face, (b) in ﬁber direction, and (c) from lateral side. (d) The model is shown
overlaid with exemplary confocal images in three orthogonal planes. The model
includes 17 complete and 21 partial myocytes. Scale: 50  m applies to (a)–(c).
% and %, respectively (Table II). Myocyte density
was and cells/mm for atrial
Fig. 8. Three-dimensional model of ventricular tissue shown from endocardial
surface. The model includes 11 complete myocytes and 11 partial myocytes.
Scale: 50  m.
and ventricular tissue, respectively. Principal component anal-
ysis demonstrated that the long (ﬁrst principal) axis of myocytes
was parallel to the surface of atrial and ventricular tissue (Figs. 7
and 8) within 6 and 3 deviation to the surface plane, respec-
tively. Furthermore, the majority of ventricular myocytes (70%)
had their second principal axis approximately parallel
to the tissue surface. In contrast, atrial tissue did not show par-
allel orientation of the second principal axis with respect to the
surface.
IV. DISCUSSION AND CONCLUSION
We described an approach for spatial modeling and analysis
of living cardiac tissue based on three-dimensional image data
obtained by scanning confocal microscopy. For that purpose,
we developed a novel method for the local delivery of ﬂuores-
cent dye and labeling of cardiac tissue, which we characterized
with standard inverted and catheter-based confocal microscopy
systems. We introduced a methodology to process stacks of mi-
croscopic images and applied it to obtain detailed spatial models
and quantitative data on cardiac microstructure. These models
and data promise to constitute important input for tissue char-
acterization and computational modeling of cardiac function.
In studies with living cardiac tissue, we demonstrated that
our novel hydrogel-based dye delivery method provided dye in
sufﬁcient concentration to yield high contrast images up to a
depth of m. We used dextran-conjugated, lysine-ﬁxable
Texas Red dye with a molecular weight of 3 kDa. This dye is
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TABLE I
QUANTITATIVE VALUES ON RABBIT MYOCYTE GEOMETRY. VALUES ARE MEAN   SD
TABLE II
RABBIT MYOCYTE DENSITY. VALUES ARE MEAN   SD
hydrophilic and penetrated the endo- and epicardium, but not
intact cell membranes. We obtained similar results with other
dextran-based dyes (data not shown), such as 10 kDa lysine-ﬁx-
able Texas Red, and 3 and 10 kDa Alexa Fluor 488 (Molecular
Probes, Eugene, OR). These ﬁndings are related to those of An-
dries and Brutsaert [28], who demonstrated that dextran-conju-
gated Lucifer Yellow with a molecular weight of 10 kDa dif-
fused through the ventricular endothelium of rat hearts. Their
study also demonstrated that a dye with a molecular weight of
40 kDa did not penetrate the endothelium.
Our studies revealed that the dye delivery method enables
imaging of tissue sections at micrometer resolution immedi-
ately after contact of the tissue surface with the dye carrier.
The applied dye resulted in high contrast between the intracel-
lular and extracellular space; showing myocytes and the extra-
cellular space as regions with low and high signal intensities,
respectively [Fig. 4(b)–(d) and Fig. 5(b)–(d)]. In the endo- and
epicardium, collagen ﬁbers appeared bright in comparison to
the surrounding space [Fig. 4(a) and Fig. 5(a)]. We suggest that
the large signal intensity of collagen ﬁbers is caused by binding
of collagen to lysine residues of the dye [34]. In the interstitial
space, larger strands of collagen ﬁbers appeared to be parallel
to myocytes [Fig. 4(b)–(d) and Fig. 5(b)–(d)].
We tested our method for dye delivery also with a catheter-
based confocal imaging system (FCM1000, Leica, Wetzlar,
Germany) applied to an isolated rabbit heart mounted and
Langendorff-perfused. We demonstrated that the dye delivery
method can be used in this type of preparation, and obtained
two-dimensional images of atrial tissue [Fig. 3(b)]. The applied
catheter-based system has a lower resolution than standard
confocal imaging systems, and is not capable of acquiring
three-dimensional stacks of images. These technical limita-
tions of the current catheter-based systems are expected to be
overcome in the near future and catheter-based high resolution,
three-dimensional confocal imaging systems will provide
data similar to standard systems [9], [11]. Thus, an important
perspective of the described approach is related to established
clinical catheterization techniques, which allow minimally
invasive access to the heart of patients and are commonly
used for electrophysiology and interventional cardiology. We
suggest that a combination of the presented approach of dye
delivery with catheter-based confocal microscopy and clinical
catheterization techniques will allow for patient-speciﬁc mod-
eling of cardiac tissue structure.
Using a standard confocal imaging system, the approach al-
lowed us to spatially reconstruct and characterize myocyte ar-
rangements in atrial and ventricular tissue. The reconstructions
can serve as spatial domains for simulations of cardiac con-
duction using methods developed previously [21], [27]. Fur-
thermore, we presented statistical data on myocyte geometry,
volume fraction and density. These data can be used in mono- or
bidomain models of cardiac conduction as described by Smaill
et al. [7] andHooks et al. [6], as well as for discretemultidomain
models that use idealized geometry such as Roberts et al. [27].
Analysis of myocyte geometry yielded lengths, widths and
heights similar to those reported in literature for rabbit cardiac
tissue (Table I). The atrial myocyte length of m
was slightly lower than previously reported lengths between
107.9 and 140.8 m [35], [36]. The atrial myocyte width
is within the reported range [35]–[37]. Also, the ventricular
length and width are within the reported range [38], [39]. Previ-
ously reported myocyte volumes are in general larger than our
calculated volumes. Speciﬁcally, our average atrial myocyte
volume of 4901 m is below the reported range of 9056 to
33 000 m , and our average ventricular myocyte volume of
10 299 m is approximately one-third of the value reported
in literature of 30 400 m . This difference in volume can be
explained by the method for approximating myocyte geometry.
Our method is based on a geometrically accurate reconstruc-
tion, whereas others approximated myocytes to be brick- or
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cylinder-shaped with cell height equal to cell width. Assuming
brick- or cylinder-shaped myocytes and calculating myocyte
volume based on our calculated length and width, our myocyte
volume would increase approximately three-fold. Thus, these
approximations and the lengths and widths determined in this
study would give similar values to those reported in literature.
Differences in myocyte geometry might also be related to
our experimental approach. Most literature values of myocyte
geometry were from isolated cells, which was suggested to be
different in tissue [35]. Furthermore, most previous studies on
myocyte geometry were based on analysis of two-dimensional
image data, which do not allow for complete three-dimensional
characterization.
Further analysis quantiﬁed myocyte volume fraction and my-
ocyte density in atrial and ventricular tissue sections (Table II).
These data are important parameters inmodeling studies of elec-
trical conduction in cardiac tissue [21]. The ventricular myocyte
volume fraction of 79.7% is similar to the reported 75.4% for
rabbit tissue [12] and 81.0% for rat tissue [13]. An underestima-
tion of myocyte volume fraction can be expectedwith our exper-
imental approach, because it applied tissue sections which were
not arterially perfused (see Limitations). Myocyte volume frac-
tions in rabbit atrial tissue have not been reported previously.
Myocyte density was approximately double in atrial tissue com-
pared to ventricular tissue ( versus
cells/mm ). This is mainly caused by the smaller size
of atrial myocytes (4901 m in atrial versus 10 299 m in
ventricular). The volume fraction of ventricular myocytes was
10.1% larger than atrial myocytes. The overestimation of my-
ocyte volumes in previous studies as well as the difference be-
tween atrial and ventricular myocyte volume fractions are note-
worthy, in particular, with respect to improving computational
modeling of cardiac electro-mechanics.
The approach enables quantiﬁcation of myocyte geometry,
volume fraction and density, which are known to be altered in
aging cardiac tissue and cardiac diseases such as hypertrophy,
atrophy, infarction and ischemia (see Section I). We suggest that
the described approach can also be applied to create models and
quantitative descriptions of microstructures in diseased tissue.
In particular, the labeling of collagen that was demonstrated
might allow spatial characterization of the extent of ﬁbrosis.
In aging atrial bundles, ﬁbrosis is a common phenomenon and
responsible for the side-to-side decoupling of atrial myocytes
[21]. Furthermore, ﬁbrosis is known to occur not only in in-
farcted regions of the heart but in surrounding regions as well
[19]. Similarly, we expect that the approach can be used to
model and quantify effects of ischemia and edema on cardiac
microstructure.
Limitations: Several limitations of this study are related to
optical properties of confocal imaging systems. Spatial reso-
lution is arguably the most signiﬁcant of these limitations for
our application. The spatial resolution can be estimated from
measured PSFs. In general, PSFs from confocal imaging sys-
tems are anisotropic, but transversally isotropic. Typically, the
full width at half-maximum is 2–3 times larger in the direc-
tion of the laser beam compared to directions orthogonal to it
[40]. Our measurement of PSFs for the BioRad MRC-1024 sug-
gest that we can separate points having a distance of 1.85 and
0.30 m in the laser beam direction and transvere to it, respec-
tively, in the unprocessed data. With our manual approach this
resolution proved to be sufﬁcient for myocyte segmentation and
characterization. However, reconstruction of small structures,
such as the transverse tubular system, appear to be difﬁcult. In
previous studies, we used a 60x oil-immersion objective lens
and shorter excitation/emission wavelengths for imaging of iso-
lated living ventricular myocytes [31]. These imaging condi-
tions caused a higher spatial resolution and enabled us to recon-
struct the transverse tubular system. Similar conditions could
be useful for imaging of tissue with submicrometer resolution.
Further limitations are related to depth-dependent attenuation
of signal intensity and our compensation approach; a mono-ex-
ponential description of attenuation. This model ﬁts the signal
from our tissue studies, but appears rather coarse with respect to
the various causes of attenuation. In an attempt to estimate atten-
uation of our optical imaging system, we imaged regions of ho-
mogenous dye concentration and similar depth as in our tissue
studies. Again, the signal ﬁt our monoexponential model, but
the analysis indicates that only one-third of attenuation in our
tissue studies is caused by system properties. The analysis sug-
gests that other causes contribute signiﬁcantly to attenuation. A
probable cause is dye diffusion from the carrier into the tissue,
which can be expected to establish depth-dependent dye con-
centrations [41]. Furthermore, attenuation might differ in tissue
and water. While these limitations did not inhibit our ability to
obtain the presented models, improved signal quantiﬁcation ap-
pears possible by more detailed modeling of attenuation, in par-
ticular separating dye diffusion-related attenuation from atten-
uation caused by system and media properties.
A limitation of our evaluation of the imaging approach is re-
lated to contractility of cardiac tissue. Motion caused by tissue
contraction will introduce artifacts, especially for three-dimen-
sional imaging. Similar difﬁculties from motion are common
with other cardiac imaging techniques such as magnetic res-
onance imaging and computed tomography. Methods for trig-
gered image acquisition and a posteriori selection of image data,
commonly based on electrocardiography, have been developed
in the past to attenuate this problem [42].We suggest that similar
methods will allow for reduction of motion artifacts in confocal
imaging of tissue microstructure.
Further limitations include our experimental approach using
isolated tissue sections. Tissue dissection causes damage to su-
perﬁcial cells. To circumvent this limitation we did not image
near regions where cuts were made. Furthermore, our tissue sec-
tions were not arterially perfused, but instead submerged in so-
lution. This lack of perfusion pressure on the tissue can cause
reduction of the extracellular space and degrade tissue viability.
Some image stacks exhibited myocyte-shaped regions of high
signal intensity [Fig. 5(c), bottom right]. We suggest that these
are cells with a compromised membrane allowing dye to pen-
etrate into the intracellular space. Additionally, some of these
image stacks with myocyte-shaped regions of high signal inten-
sity exhibited motion artifacts. The motion appears to be caused
by apoptosis relatedmembrane damage, calcium inﬂux and con-
tracture of the affected cells. We rejected images with motion ar-
tifacts from further processing. Additionally, some of our image
stacks exhibited low SNR, which resulted from difﬁculties in
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moving the tissue surface in close proximity to the coverslip.
These difﬁculties are caused by irregularity of the surfaces of
the cardiac tissue samples. Overall, these limitations do not af-
fect the application of our described method.
Other limitations are associated to our image processing ap-
proach. Automated approaches for myocyte segmentation in the
described image data are currently not available. Our ﬁrst step
for segmentation of myocytes was based onmanual deformation
of triangular meshes. This manual process was accomplished
with the user’s discretion. Furthermore, threshold values to dis-
tinguish intra- from extracellular space were chosen from his-
tograms of voxel intensity. A bimodal distribution of voxel in-
tensity would facilitate the separation of the intra- from the ex-
tracellular space. However, intensity distribution was not bi-
modal, but showed a normal to right-skewed distribution. Al-
though threshold values were ultimately based on mode and
standard deviation for each segmented myocyte, the value used
was based on qualitative evaluation of the spatially modeled
myocytes.
Another limitation is related to the usage of other dyes with
the described dye delivery approach. With this approach, the
applied dye readily diffused from the hydrogel carrier through
the endo- or epicardium into the myocardium. We did not test
the delivery approach with other dyes (see exceptions above).
We expect that hydrophobicity of ﬂuorescent dyes and their
Stokes’ radius, which takes into account size and shape, will
determine their applicability using our approach. Of particular
interest are dyes for functional characterization of cardiac tissue.
Labelingwith voltage and calcium sensitive dyes are established
approaches for characterizing cardiac wave conduction and ex-
citation-contraction coupling, respectively.
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Controlling environmental conditions, such as mechanical stimuli, is critical for directing
cells into functional tissue. This study reports on the development of a bioreactor capable of
controlling the mechanical environment and continuously measuring force-displacement in
engineered tissue. The bioreactor was built from off the shelf components, modiﬁed off the
shelf components, and easily reproducible custom built parts to facilitate ease of setup,
reproducibility and experimental ﬂexibility. A T-ﬂask was modiﬁed to allow for four tissue
samples, mechanical actuation via a LabView controlled stepper motor and transduction of
force from inside the T-ﬂask to an external sensor. In vitro bench top testing with instrumen-
tation springs and tissue culture experiments were performed to validate system perform-
ance. Force sensors were highly linear (R2 [ 0.998) and able to maintain force readings
for extended periods of time. Tissue culture experiments involved cyclic loading of polyur-
ethane scaffolds seeded with and without (control) human foreskin ﬁbroblasts for 8 h/day for
14 days. After supplementation with TGF-b, tissue constructs showed an increase in stiffness
between consecutive days and from the acellular controls. These experiments conﬁrmed the
ability of the bioreactor to distinguish experimental groups and monitor tissue stiffness dur-
ing tissue development. VC 2010 American Institute of Chemical Engineers Biotechnol. Prog.,
26: 857–864, 2010
Keywords: bioreactor, tissue engineering, tissue stiffness, ﬁbroblast
Introduction
Tissue engineering requires appropriate starting materials,
environmental cues, and temporal orchestration to produce a
tissue product that is effective for its intended use and safe
if used for transplantation. Environmental cues, such as
chemical and mechanical stimuli, play an essential role in
the growth and development of engineered cells and tissues.
Mammalian cells and in particular cardiac cells are subjected
to external and intracellular mechanical forces in vivo, which
determine the fundamental function of cell migration, prolif-
eration, differentiation, and therefore tissue properties.1–4
Appropriate mechanical stimuli direct various cells to de-
velop into structurally and functionally mature tissue both in
vivo and in vitro. Applying inappropriate stimuli can alter
the cell phenotype, tissue properties and produce unorgan-
ized, stiff, ﬁbrotic tissue that is implicated in various types
of end stage organ failure.5 Therefore it is important to not
only control but also monitor mechanical stimuli in certain
types of engineered tissue. This article reports on the devel-
opment of a bioreactor designed to control the mechanical
environment for engineered tissue constructs while continu-
ously measuring their mechanical properties as a function of
time. This type of bioreactor can be used to study tissue en-
gineering variables and pathways associated with the devel-
opment of normal and pathogenic tissue.
In cardiac tissue engineering the electromechanical envi-
ronment plays an important role in deﬁning the cardiac pheno-
type. These environmental variables can be used to direct
tissue development and alter both structure and function.
Electrical stimulation in two-dimensional myoblast cell cul-
tures has been found to increase the expression of the gap
junction protein, connexin43 (Cx43), which is the predomi-
nant connexin isoform in ventricular tissue.6 Connexins are a
hallmark of the cardiac phenotype and responsible for cou-
pling the cytoplasmic compartments of adjacent myocytes to
allow the rapid propagation of electrical signaling. Varying
mechanical cues such as substrate stiffness and possibly over-
stretching can lead to expression of gap junctions in myoﬁbro-
blasts which electrically couple to cardiomyocytes leading to
irregular current propagation.5,7 Mechanical stretching has
also been found to enhance cell proliferation and matrix orga-
nization of neonatal rat myocytes8 and human heart cells.9
Likewise, in three-dimensional (3D) cell cultures, electrical
stimulation was shown to induce myocyte alignment and
increase electrical coupling via Cx43 upregulation,10 while
mechanical stimulation was shown to increase the contractile
force of engineered tissue constructs.3 These studies demon-
strate the importance of environmental conditions on directing
the growth and development of cells towards useful tissue.
To understand the effects of external stimuli, researchers
in the ﬁeld of cardiac tissue engineering have developed
unique and elegant tools for developing and studying engi-
neered cardiac tissue.4,11–13 A variety of bioreactor systems
have been developed to directly control environmental cues
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while overcoming limitations inherent in static culture plat-
forms. Spinner-ﬂask bioreactors overcome the mass-transfer
limitations of static culture environments and have shown
improved cell seeding and development of cardiac tissue con-
structs.14 Similarly, rotating wall vessels are capable of produc-
ing low levels of shear stress while improving mass-transfer
rates, and have demonstrated the ability to create elongated
myocytes and spontaneously contracting cardiac tissue con-
structs.14 Direct perfusion systems have overcome limitations
of poor cell inﬁltration and nonuniform cell coverage in 3D tis-
sue constructs and have been shown to enhance cell survival,
growth, and function in many engineered tissue types.15,16
Bioreactors capable of applying mechanical stimulation to
3D cardiac tissue to direct myocyte development have been
developed.12,17 Moreover, a bioreactor capable of applying
both mechanical and electrical stimulation to cardiomyocytes
and measuring their mechanical properties has been devel-
oped.1 Although these tools meet their intended function,
they are typically developed to meet the needs of a single
laboratory and targeted towards a speciﬁc series of experi-
ments. Therefore, there is a need to develop a more robust
bioreactor capable of handling experimental ﬂexibility,
reproducibility, and economy. Although these goals are still
on the horizon, we believe that the use of common cell cul-
ture equipment, open source designs and integrated sensing
will enable life science labs without device fabrication capa-
bilities to utilize these tools in tissue engineering, drug dis-
covery, and basic science research. In addition, these types
of designs can motivate future generations of bioreactors and
take advantage of plate and ﬂuid handling equipment that is
routinely used for high throughput assays.
In this study, a next generation bioreactor capable of con-
tinuously measuring mechanical properties of cultured tissue
was developed based on a previous design.18 The previous
bioreactor was designed speciﬁcally for engineering vocal
fold tissue from primary human laryngeal ﬁbroblasts. The
bioreactor was capable of applying mechanical stimulation
via a stepper motor controlled with LabView. To continu-
ously monitor mechanical properties of cultured tissue, the
bioreactor was signiﬁcantly modiﬁed to incorporate force
sensors for real time monitoring of force-displacement. This
characterization of mechanical properties during tissue devel-
opment provides nondestructive, real time feedback that can
be used to control culture variables and assess experimental
endpoints. Furthermore, the bioreactor was designed such
that future modiﬁcations speciﬁc towards cardiac tissue engi-
neering, such as perfusion and electrical stimulation, could
be easily implemented without redesigning the system.
The central goal of this study was to develop a bioreactor
capable of controlling the mechanical environment and con-
tinuously measuring force-displacement in engineered tissue.
In addition, we speciﬁed that the bioreactor be built from off
the shelf components, was easy to setup, reproducible, and
ﬂexible in its experimental capabilities. To accomplish this
goal, we designed the bioreactor to meet these needs and
performed in vitro bench top and tissue culture experiments
to validate its performance.
Materials and Methods
Bioreactor design
A cell culture ﬂask (T-75, Corning, Lowell, MA) was
modiﬁed using a custom built ﬁxture and CNC machine
(MAXNC 15, Gilbert, AZ) to allow easy access to four tis-
sue samples, linear actuation, and a magnetically coupled di-
aphragm assembly to measure applied forces. The top and
force sensing sides of the ﬂask were modiﬁed using a 0.32
cm diameter end mill at a motor speed of 1000 rpm and
feed rate of 10.2 cm/min. The linear actuation side was
modiﬁed using a 0.48 cm diameter end mill at a motor speed
of 1000 and feed rates ranging from 1.3 to 10.2 cm/min. To
secure the T-ﬂask to the bioreactor base, extruded acrylic
strips (Ridout Plastics, San Diego, CA) were mounted to the
bottom (0.64 cm x 1.3 cm x 6.1 cm) and sides (0.64 cm x
1.3 cm x 2.6 cm) using UV curable adhesive (Loctite 3201).
To maintain sterility during tissue culture, the modiﬁed cul-
ture ﬂask was sealed on the three modiﬁed sides. A replacea-
ble, self adhesive, clear polyester lid (mylar, Fralock,
Valencia, CA) was designed to cover the ﬂask’s top opening
and allow access to tissue. The linear actuation port holes
are equal to the diameter of the stainless steel access rods,
and the force sensing surface has elastomeric polyurethane
diaphragms (described later).
Linear actuation was accomplished using a two phase
bipolar stepping motor (PK244-04A, Oriental Motor, Tor-
rance, CA), microstep motor drive (G201, Geckodrive, Tus-
tin, CA), linear slide (NSK, Clarinda, IA), and belt-pulley
system (SDP/SI, New Hyde Park, NY). Tissue forces were
measured using four full bridge strain gauge force sensors
(SMD, Wallingford, CT) secured in custom built aluminum
housings with overload stops. Each load sensor is a double
cantilever, stainless steel beam with a silicon nitride passiva-
tion layer and laser lithographed thin ﬁlm nichrome sensing
layer. The sensor is conﬁgured as a full Wheatstone bridge
with four leads attached for providing excitation and signal
voltages. The sensor is rated at 100 gf with a symmetric
bridge resistance of 10 kX. Miniature neodymium magnets
were used to magnetically couple each sensor to the tissue
sample across ﬂexible 0.05 mm polyurethane diaphragms
(Converters, Huntingdon Valley, PA) attached to the side of
the T-ﬂask. The elastomeric diaphragms allow force from
within the culture environment to be translated to an external
transducer. This novel feature allows for noninvasive and
nondestructive characterization of mechanical properties dur-
ing tissue development. The stepper motor was controlled
using a custom LabView program (version 8.2) and a multi-
function data acquisition (DAQ) card (PCI-6221, National
Instruments, Austin, TX).
Bioreactor characterization and testing
Before bioreactor assembly, force sensors were character-
ized for sensitivity, DC offset, and linearity. Forces ranging
from 0 to 100 gf were applied in increments of 20 gf. Sen-
sors were powered with 10 V excitation (as in the all the fol-
lowing tests) using a DC power supply (E3648A, Agilent
Technologies, Santa Clara, CA). Output voltages were
recorded using a data acquisition unit (34970A, Agilent
Technologies, Santa Clara, CA).
Once sensors were characterized, the bioreactor was
assembled and system veriﬁcation was performed using
instrumentation springs to mimic tissue constructs (3 gf/
mm, McMaster-Carr, Atlanta, GA). The stiffness of the
instrumentation springs (3 gf/mm) was similar to that of
the elastomeric polyurethane scaffolds used in this study.
The bioreactor was placed in an incubator at 37C and sen-
sor drift, linearity and repeatability were tested using
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LabView controlled motion patterns for 62 h. Displacements
of 2, 4, 6, 8, and 10 mm were held for 2 h each in both
ascending and descending motion paths. This displacement
proﬁle was repeated three times over the 62 h test period.
Force was measured every minute over the duration of the
study. The average of each force plateau was calculated and
linear regression was performed on the ascending and de-
scending sides. Furthermore, the intra- and inter-plateau
range was calculated to yield a maximum variation for each
plateau.
The ability of the sensors to record force at multiple dis-
placements and speeds was assessed in a two stage experi-
ment. First, speeds of 1, 2, 4, 8, and 16 mm/s (0.25, 0.50, 1,
2, and 4 Hz, respectively) were used to cyclically displace
springs to 2 mm (4% strain). In the second experiment,
springs were cyclically displaced to 1, 2, 5, and 10 mm (2%,
4%, 10%, and 20% strain) at a ﬁxed speed of 2 mm/s. Force
readings at minimum and maximum displacements were
used to calculate spring constants.
Forces were recorded at a sampling rate of 1,000 Hz on
the DAQ and analyzed using MATLAB (Mathworks, Natick,
MA). Recordings were baseline corrected and ﬁltered with a
10- to 20-point moving average. Sensor noise levels were
also determined in the postrecording processing by calculat-
ing the standard deviation of a constant force reading.
Scaffold fabrication and characterization
Porous polyurethane scaffolds were selected for prelimi-
nary tissue culture experiments to validate the bioreactor’s
capability of distinguishing experimental groups. The polyur-
ethane scaffolds have elastomeric properties, allowing them
to be mechanically stretched during tissue culture.19 To fab-
ricate the porous polyurethane scaffolds, we adapted a previ-
ously described method from Titze et al.18 Polyurethane
pellets (Tecoﬂex SG-8, Lubrizol, Wickliffe, OH) were mixed
with the solvent dimethylacetamide (DMAC) at a concentra-
tion of 0.4 g/mL and dissolved overnight at 60C. Poloxamer
(33% v/v) (Pluronic 10R5, BASF, Ludwigshafen, Germany)
was added and the solution thoroughly mixed. The polymer
solution was cooled to 46C and poured into polymer molds.
Polymer ﬁlled molds were further cooled for 2.5 min
through surface contact with a dry-ice/ethanol bath and pre-
cipitated overnight in a room temperature DI water bath.
Precipitated scaffolds were separated from the molds, rinsed
in DI water for 48 hours, frozen to 80C, and lyophilized.
Lyophilized scaffolds were sectioned into strips (30 mm x
10 mm x 2 mm) and attached to 0.30 mm thick polyester
(mylar, Fralock, Valencia, CA) mounts using medical grade
UV curable adhesive (MD 1180, Dymax, Torrington, CT).
Mounted scaffolds were ethylene oxide sterilized, soaked for
20 min in 70% ethanol to promote wetting, rinsed in DI
water, and incubated at 37C for 2 h in a ﬁbronectin solution
(20 mg/mL in PBS) (Invitrogen, Carlsbad, CA) to promote
cell attachment.
Mechanical properties of the scaffolds were characterized
using an Instron 3342 (Instron, Norwood, MA) at a gauge
length of 20 mm (n ¼ 5). The samples were tested to failure
at a strain rate of 2 mm/s. The elastic modulus was calcu-
lated by plotting stress (force divided by cross-sectional
area) and strain data. Scaffold porosity was calculated by the
ratio of the void space to total volume of the scaffold (n ¼
10).20 Total volume was calculated by multiplying the
length, width, and height of rectangular samples. The mass
of the samples were multiplied by the speciﬁc gravity of
Tecoﬂex SG-8 (1.04 g/cm3) to determine the volume of pol-
yurethane material. The total volume minus the volume of
polyurethane determined the volume of void space. Porosity
was the ratio of void space to total volume.
Tissue culture experiment
Human foreskin ﬁbroblasts (HFFs, ATCC, Manassas, VA)
were selected because they are primary cells capable of
secreting human ECM.21 Deposition of ECM proteins is
known to inﬂuence mechanical properties of the tissue con-
struct during culture.22 One of the bioreactor design goals
was to characterize these mechanical property changes with
our built in force sensor. Cells were passaged no more than
three times before seeding. In preparation for scaffold seed-
ing, frozen HFFs were thawed, plated onto T-175 ﬂasks, and
grown to conﬂuency in DMEM/F12 (Gibco) with 10% FBS
(Gibco) and 25 lg/mL gentamicin (Sigma). Conﬂuent cul-
tures were disassociated with 0.25% trypsin and 1 mM
EDTA, centrifuged, and resuspended in DMEM/F12. Cells
were counted with a hemocytometer using the trypan blue
exclusion method and seeded onto scaffolds at a density of 2
million cells/scaffold.
Tissue constructs were placed in the bioreactor and preten-
sioned to 3 gf. The tissue constructs were cultured for 14
days and subjected to 10% strain (2 mm displacement) for 8
h a day followed by 16 h of rest. The strain proﬁle consisted
of an active phase of 2 sec and a resting phase of 2 sec. The
active phase consisted of straining the construct at a speed
of 2 mm/s and returning to 0% strain for 2 sec. Samples
were maintained in a growth medium consisting of DMEM
F12 supplemented with 10% FBS, gentamicin, and 1 mM
ascorbic acid. Beginning on day 8 the growth medium was
supplemented with recombinant human transforming growth
factor beta 1 (rhTGF-b1, Peprotech, Rocky Hill, NJ) at a
concentration of 4 ng/mL. Nonseeded scaffolds were main-
tained as controls. Stiffness of tissue samples (n ¼ 4) and
acellular controls (n ¼ 4) were measured daily during the 14
days of culture. Stiffness was deﬁned as force divided by
displacement, which is analogous to a spring constant and
reported as grams of force per millimeter of displacement.
Stiffness values for each construct were normalized to day 1
and averaged to obtain a mean and standard deviation of the
percent change in stiffness. Media was changed every 2–3
days. Instrumentation springs were placed in the bioreactor
before and after the 14-day culture period and the spring
constants were measured to verify sensor response.
Histological analysis
At day 14, samples from each tissue construct were
stained with ﬂuorescein diacetate (FDA) and propidium
iodide (PI) to characterize cell viability according to the
manufacturer’s guidelines (Invitrogen, Carlsbad, CA). Fol-
lowing FDA-PI staining, samples were washed with PBS
and ﬁxed with 4% paraformaldehyde for 20 min. Triton X-
100 was used to permeabilize the cell membrane and cells
were trilabeled for a-smooth muscle actin, F-actin, and
nuclei. Cells were stained for a-smooth muscle actin using
an IgG2a conjugated anti-actin a-SMA primary antibody
(Sigma-Aldrich, St. Louis, MO) as previously described.23
Alexa Fluor 594 goat anti-mouse IgG (HþL) was used as a
ﬂuorescing secondary antibody (Invitrogen, Carlsbad, CA).
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F-actin was stained with phalloidin conjugated to Alexa
Fluor 488 (Invitrogen, Carlsbad, CA). DAPI was used as a
counterstain to visualize cell nuclei. Images were acquired
using an FV1000 confocal microscope using a 40x objective
and a ﬁeld of view of 1024 x 1024 pixels (Olympus, Center
Valley, PA).
Statistical analysis
ANOVA and post-hoc t-tests were performed to determine
statistical signiﬁcance with an a ¼ 0.05.
Results
Bioreactor assembly
The bioreactor was assembled with a combination of off
the shelf components, modiﬁed off the shelf components,
and easily reproducible custom built parts (Figure 1). The
programmable CNC machine allowed for rapid, accurate,
and repeatable modiﬁcation of the T-75 ﬂask (Figures
1A,B). The machined aluminum sensor housing prevented
overload and provided a rigid structure to secure the sensor
(Figures 1D,E). Flexible polyurethane diaphragms (Figure
1C) were used to mechanically couple the force sensors (Fig-
ure 1F) to the tissue constructs (Figure 1G).
Bioreactor characterization
All four sensors exhibited high linearity with R2 [ 0.998
(Figure 2A). Sensor sensitivity ranged from 7.79  103 to
9.87  103 mV/V/gf with DC offsets ranging from 0.0599
to 0.183 mV/V. Sensors exhibited approximately 0.31 gf
of noise in the raw signals and was reduced to approximately
0.08 gf in the ﬁltered signals.
Sensors maintained linearity (R2[ 0.999) after bioreactor
assembly and spring attachment. Furthermore, sensors main-
tained force readings over extended periods of time and
returned to the same force for a given displacement (Figure
2B). The maximum range of force values recorded within a
speciﬁed displacement (i.e. intra-plateau variation) was 0.22
gf. The maximum range of force values recorded between a
speciﬁed displacement (i.e. interplateau variation) was 0.58
gf.
Sensors A, B, and C showed signiﬁcantly different meas-
ured spring constants with varying speeds at a ﬁxed displace-
ment (ANOVA, p \ 0.05 for all sensors) (Figure 3A).
However, sensor D showed no statistically signiﬁcant differ-
ence between measured spring constants in the same experi-
mental conditions (ANOVA, p [ 0.078 for all sensors).
Post-hoc t-tests showed many speed groups being different
from one another. All sensors displayed a statistically signiﬁ-
cant difference in spring constants for varying displacements
at a ﬁxed speed (ANOVA, p\ 0.05 for all sensors) (Figure
3B). Post-hoc t-tests showed many displacements being dif-
ferent from one another. Although there were statistically
signiﬁcant differences between the measured spring con-
stants, the standard deviation was less than 0.10 gf/mm for
all sensors. Moreover, the maximum range for measured
spring constants was 0.21 gf/mm (8% of measured spring
constant) for a ﬁxed displacement and varying speeds, and
Figure 1. Assembled bioreactor (center photograph) with zoomed regions.
(A) Unmodiﬁed culture ﬂask. (B) Exploded view of modiﬁed culture ﬂask showing polyester lid (top) and side ports for linear actuation (back) and
force transduction (front). (C) Zoomed view of magnet-diaphragm assembly shown by dashed box in panel B. Force is transferred across diaphragm
through magnets. (D) Sensor overload housings. (E) Exploded view of sensor sandwiched between overload housing. (F) Full bridge strain gauge
force sensor. (G) Spring (top) for system veriﬁcation testing and tissue scaffold (bottom) attached to polyester mounts for tissue culture experiments.
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0.16 gf/mm (6% of measured spring constant) for a ﬁxed
speed and varying displacements.
Scaffold characterization
The elastic modulus of the scaffold was 38.9  8.9 kPa,
calculated from the linear range of the stress–strain curve,
which corresponded to 0–40% for all samples. The scaffolds
were highly elastic, displaying a strain to failure at 301.0 
51.4% with an ultimate stress of 88.6  23.5 kPa. Scaffolds
porosity was 95.3  0.8 %.
Tissue culture
Tissue constructs showed an increase in tissue stiffness
over the 14 day culture duration (Figure 4). Following sup-
plementation with TGF-b on day 8, statistically signiﬁcant
differences between consecutive days were observed (p \
0.05). Furthermore, the tissue constructs were statistically
different from the acellular control (p\ 0.05) on days 10 to
14. The porous polyurethane scaffolds (Figure 5A) showed
excellent coverage by the ﬁbroblasts (Figure 5B). Live/Dead
imaging resulted in 100% observable cell viability with no
dead cells or necrotic zones at the end of cell culture (Figure
5B). Fibroblasts stained positive for a-smooth muscle actin
and ﬁlamentous actin (F-actin) (Figure 5C). To ensure sensor
sensitivity was preserved during tissue culture, spring con-
stants were measured before and after the experiments.
Measured spring constants before and after the 14-day cul-
ture period were within 4%.
Discussion
Controlling environmental conditions, such as the chemi-
cal and mechanical stimuli, is important in guiding cells into
Figure 3. (A) Measured spring constants for sensor A with varying speeds of 1, 2, 4, 8, and 16 mm/s at a cyclic displacement of 2 mm
(error bars denote standard deviation); (B) measured spring constants for sensor A with cyclic displacements of 1, 2, 5, and
10 mm at a ﬁxed speed of 2 mm/s (error bars denote standard deviation).
Figure 2. (A) Sensor characterization for four sensors A, B, C, and D.
Output voltage was normalized to constant input voltage. (B) Drift and repeatability of sensor A in assembled bioreactor showing ﬁrst 22 hours of
62 h experiment (note: error bars smaller than data points).
Figure 4. Percent change in stiffness of tissue constructs nor-
malized to day 1.
Error bars denote standard deviation. TGF-b added on day 8.
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functional tissue.1–4 In this study, a bioreactor capable of
controlling the mechanical environment and interrogating
mechanical properties of engineered tissue was developed
and veriﬁed through bench top testing and tissue culture
experiments. The bioreactor is an open source tool and
access to the assembly drawings, bill of materials, machined
part drawings, LabView programs, and G-codes for the CNC
machine are available by contacting the corresponding
author.
A novelty of our bioreactor is the magnet-diaphragm as-
sembly used to translate force from within the culture envi-
ronment to an external transducer. This novel feature
allows for nondestructive characterization of mechanical
properties during tissue development, which is important in
high throughput monitoring techniques needed in pharma-
ceutical testing.24,25 Furthermore, the force of contraction is
an important parameter for assessing the functional proper-
ties of engineered cardiac tissue.1,3 Using magnets coupled
across a thin polyurethane diaphragm reduces the moment
applied to the transducer. Computer modeling and bench
testing (data not shown) support the performance of the di-
aphragm/magnet coupling assembly in maintaining sensitiv-
ity and linearity when transmitting forces out of the culture
chamber to an externally located force sensor. Other meth-
ods for mechanical coupling that include moving parts and
seals were considered, but excluded due to inherent nonli-
nearity and hysteresis, which leads to inaccuracy and lack
of precision.
The sensors were highly linear before and maintained line-
arity after bioreactor assembly (Figure 2). The drift and
repeatability test demonstrated that the sensors were able to
maintain force readings for extended periods of time and
return to the same force reading for a given displacement.
The maximum range of force values for intra- and inter-pla-
teau was 0.22 and 0.58 gf, respectively. Furthermore, the
measured spring constants at varying speeds and displace-
ments were within a range of approximately 8% and 6% of
the average spring constant, respectively (Figure 3). To
address this limitation, lower speeds (2 mm/s), which
increased spring constant reproducibility to within 2.9%
were used to measure tissue stiffness during tissue culture.
In this study, tissue constructs were stretched 2 mm, which
resulted in a maximum force reading of approximately 8 gf.
Therefore, only approximately 8% of the full range (100 gf
full range) of the sensor was utilized during tissue culture.
Using only 8% of the total range of the sensor leads to mea-
surement inaccuracies, which is one limitation of the current
study, however, the bioreactor was designed such that the
sensor can be easily replaced to incorporate sensors with
desired ranges.
The polyurethane scaffolds were highly elastic and
allowed for seeding, proliferation, and mechanical condition-
ing of cells during the tissue culture experiments. Previous
studies using the same material demonstrated that polyur-
ethane scaffolds can be fabricated with tunable mechanical
properties.26 The ability to tune the mechanical properties
and create thicknesses ranging from 50–5000 lm provides a
tissue engineering scaffold material that can be used for
both bench top and implant applications. Although this ma-
terial is nondegradable, it can serve as a sacriﬁcial template
for a biosynthetic scaffold material. In this application, cells
are seeded and secrete a continuous extracellular matrix con-
sisting primarily of ﬁbrillar collagen. The cultured construct
can then be processed with ﬁxatives, detergents, and an or-
ganic solvent, leaving a material that is similar in form to
the original template but containing only secreted ECM
products.22
The tissue culture experiment with ﬁbroblasts demon-
strated the ability of the bioreactor to control the mechani-
cal environment and measure mechanical properties of the
tissue during development. Furthermore, the bioreactor was
able to measure differences between the acellular control
and tissue constructs seeded with ﬁbroblasts, demonstrating
the utility of the bioreactor in distinguishing experimental
groups.
Fibroblasts stained positive for a-smooth muscle actin and
F-actin (Figure 5C). Previous studies have demonstrated that
mechanical tension can promote ﬁbroblasts to differentiate
into proto-myoﬁbroblasts, and the addition of TGF-b with
mechanical tension can promote proto-myoﬁbroblasts to dif-
ferentiate into myoﬁbroblasts.5 Myoﬁbroblasts play an im-
portant role in connective tissue remodeling and wound
healing due to their specialized contractile ability, which
includes the organization of a-smooth muscle actin into
stress ﬁbers.23 In our tissue culture experiments, a-smooth
muscle actin did not appear to organize into distinct stress
ﬁbers and was not co-localized with phalloidin suggesting
that the a-smooth muscle actin was not in F-actin form.27
However, TGF-b is known to enhance extracellular matrix
formation by ﬁbroblasts,28 suggesting that our increase in
stiffness was due to increased ECM production, however this
was not evaluated in this study. In addition, the baseline
force of the constructs did not change (data not shown) over
the 14-day culture period which further suggests the stiffness
Figure 5. Scaffold before (A) and after (B,C) after 14 days of culture.
(A) Scaffold before cell seeding. (B) Live/Dead staining viable cells green and nonviable cells red. (C) Immunoﬂuorescence staining of a-SMA
(red) counterstained with phalloidin (green) and DAPI (blue). Scale 400 lm (A, B) and 100 lm (C).
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increase was due to ECM production rather than intracellular
contractile mechanisms.
One limitation of the current bioreactor for cardiac tissue
engineering is the lack of electrical stimulation and perfu-
sion. Other studies have demonstrated the importance of the
electromechanical environment in cardiac myocytes.6,10
Future directions will include incorporating electrical stimu-
lation to mimic environmental conditions for native cardiac
tissue. Another limitation is the bioreactor’s size and more
speciﬁcally the culture density. The 3D tissue samples are
capable of culturing several times more cells than a conﬂu-
ent monolayer in a similar culture vessel, however, each T-
75 ﬂask contains four tissue constructs that are each grown
in the same culture and stimulation environment. Although
different substrates and additional samples can be used in
the same bioreactor, each reactor provides a similar environ-
ment. Intrareactor sample variables that can be adjusted in
future designs include electrical stimulation and perfusion.
The reactor has a modest footprint of 30.5 cm x 30.5 cm x
5.4 cm, which allows the placement of eight reactors in a
standard sized incubator. We foresee that the current design
requirements including 3D culture, mechanical strain, and
tissue mechanical property interrogation can be scaled down
to increase culture density and sample size.
In summary, we report here the development of a next
generation bioreactor assembled from off the shelf and easily
reproducible components that includes real time interrogation
of cultured tissue mechanical properties using a magnetically
coupled force transducer. The reactor has been characterized
for sensor drift, linearity, and repeatability as well as system
level measurement changes in response to strain rate.
Although the measured spring forces change in response to
strain rate, these changes can be used to both design the
experiment and develop strategies that decrease strain rates
during measurement cycles. Our 14-day test veriﬁed system
stability and reliability as well as the ability to routinely
measure engineered tissue mechanical properties using a
completely automated system. The design and testing of this
system provides insight into future designs that can increase
sample size and culture density while providing a current
design that can be used for studies related to the replacement
of diseased/injured myocardium as well as pharmaceutics,
genomics, and physiology research.
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CHAPTER 4 
MICROSTRUCTURAL COMPARISON OF ENGINEERED 
AND NATIVE CARDIAC TISSUE BASED ON THREE- 
DIMENSIONAL CONFOCAL MICROSCOPY 
4.1 Abstract 
Quantifying and establishing structural features of native myocardium in 
engineered tissue is essential for creating functional tissue that can serve as a surrogate 
for in-vitro testing or the eventual replacement of diseased or injured myocardium. Here, 
we applied three-dimensional confocal imaging and image analysis to quantitatively 
describe features of native and engineered cardiac tissue, focusing on myocyte geometry 
and spatial distribution of the major gap junction protein connexin-43 (Cx43). 
Quantitative analysis methods were developed and applied to test the hypothesis that 
environmental cues direct engineered tissue towards a phenotype resembling that of age-
matched native myocardium. The analytical approach was applied to engineered cardiac 
tissue with and without the application of electrical stimulation as well as to age-matched 
and adult native tissue. Individual myocytes were segmented from confocal image stacks 
and assigned a coordinate system from which measures of cell geometry and Cx43 spatial 
distribution were calculated. Data were collected from 9 nonstimulated and 12 
electrically stimulated engineered tissue constructs and 5 postnatal day 12 (P12) and 7 
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adult hearts. The myocyte volume fraction was nearly double in stimulated engineered 
tissue compared to nonstimulated (0.34±0.14 vs. 0.18±0.06, p<0.01), but less than half of 
native P12 (0.90±0.06) and adult (0.91±0.04) myocardium. Myocytes under electrical 
stimulation were more elongated compared to nonstimulated myocytes, and exhibited 
similar lengths, widths and heights as in age-matched myocardium. Furthermore, the 
percentage of membrane positive for Cx43 was similar in the electrically stimulated, P12 
and adult myocytes, whereas it was significantly lower in nonstimulated myocytes. Cx43 
was found to be primarily located at cell ends for adult myocytes and irregularly but 
densely clustered over the membranes of nonstimulated, stimulated and P12 myocytes. 
These findings support our hypothesis and reveal that the application of environmental 
cues produce tissue with structural features more representative of age-matched native 
myocardium than adult myocardium.  We suggest that the presented approach can be 
applied to quantitatively characterize developmental processes and mechanisms in 
engineered tissue. 
4.2 Introduction 
Establishing hallmarks of the native myocardium in engineered tissue is essential 
for creating functional tissue that can serve as a surrogate for in-vitro testing or the 
eventual replacement of diseased or injured myocardium [1]. Quantitative measures of 
structural and functional tissue characteristics form a technical cornerstone for the 
development and testing of engineered cardiac tissue. Native tissue is complex and 
exhibits a three-dimensional (3D) multicellular structure and function. This 3D 
microenvironment has profound effects on the properties, behavior and functions of 
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resident cells [1-3]. Furthermore, native tissue exhibits astonishing variation in the 
quantity, density, and morphology of cardiac cells during development, amongst species, 
between tissue types and in disease [4-6]. Most engineered cardiac tissue aims to 
replicate left ventricular myocardium, which is heterogeneous and comprised of densely 
packed myocytes, fibroblasts and other cell types.  
Fibroblasts account for the majority of cells in the heart and play important roles 
in normal cardiac function and disease [7, 8]. Although myocytes only account for 20-
40% of cells that make up cardiac tissue, they occupy approximately 80-90% of the tissue 
volume and are the contractile cells solely responsible for pump function [9, 10]. 
Alterations in myocyte geometry and structure are known to occur during development 
and in disease states [11-13]. Myocyte structures that are critical for cardiac function 
include sarcomeres and gap junctions.  Sarcomeres, the fundamental unit of contraction, 
occupy a large fraction of the intracellular volume and are highly aligned in healthy 
myocytes. Gap junctions allow for rapid electrical signaling between myocytes necessary 
for synchronous cardiac contraction. Connexin-43 (Cx43), the predominant isoform of 
gap junction channels in ventricular myocytes [14, 15], has a half-life of 2 hours. The 
continuous turnover allows Cx43 to redistribute along the cell surface in response to 
environmental conditions [16, 17]. The distribution of Cx43 is known to vary during 
development and in disease states [18, 19]. For example, in rat cardiac tissue, Cx43 
redistributes in response to tissue maturity. In neonatal tissue Cx43 clusters are found to 
be distributed over the myocyte membrane. As the tissue matures, Cx43 slowly becomes 
organized and at approximately 90 days after birth concentrates at the cell ends (i.e. 
polarized) [18]. Gap junctions also remodel due to disease. For example, as human 
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cardiac hypertrophy progresses into heart failure Cx43 expression decreases and 
accumulates at the lateral sides of myocytes instead of the ends (i.e. lateralized) [4, 14, 
20]. Gap junctions can be coerced to rearrange in-vitro. A recent study in 2D monolayers 
of neonatal rat myocytes indicated polarization of Cx43 localization by stretching [21]. 
The functional importance and dynamic nature of Cx43 makes it a target for analysis, and 
these types of responses may indicate some level of control over engineered cardiac 
tissue. 
Several approaches have been developed to produce 3D engineered cardiac tissue 
including seeding preformed scaffold materials with cells [22], entrapping cells in a 3D 
environment [23], stacking cell sheets [24], and decellularizing and recellularizing tissue 
[25] (Reviewed in detail in refs [26, 27]). The application of electrical stimulation [22, 
28, 29], mechanical stimulation [30-32], or perfusion [33] has been shown to aid in the 
tissue development. To investigate the structure of these engineered tissues most reported 
methods rely on qualitative interpretation of 2D images. A more comprehensive analysis 
of structure can be accomplished through 3D confocal microscopy [34, 35]. Confocal 
microscopy is based on fluorescent labeling and has the ability to control the depth of 
field (slice resolution of <1 µm), reject out-of-focus light and collect sequential optical 
sections from thick specimens [36, 37]. The application of 3D confocal imaging to 
quantitatively characterize structure has not been widely performed on engineered tissue. 
The hypothesis of this study is that the application of environmental cues directs 
engineered tissue towards a phenotype resembling that of age-matched native 
myocardium. The hypothesis was tested by applying 3D confocal imaging and image 
analysis to characterize hallmarks of cardiac tissue, including myocyte geometry and 
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spatial distribution of Cx43, in engineered cardiac tissue with and without the application 
of electrical stimulation. The results of the study support our hypothesis and reveal that 
the application of environmental cues produce tissue with structural features resembling 
age-matched native myocardium as opposed to adult tissue. 
4.3 Methods 
4.3.1 Cell Isolation 
All animal procedures were performed in accordance with an approved protocol 
by the University of Utah Institutional Animal Use and Care Committee. Ventricular 
cardiac cells were harvested from 1-day old Sprague-Dawley rats (Charles River, MA) 
using a protocol and supplies from Worthington Biochemical (Lakewood, NJ). Briefly, 
hearts were aseptically removed and collected in calcium-and magnesium-free Hank’s 
balanced salt solution. Atria were removed and the ventricles were finely minced and 
digested in 50 µg/mL trypsin at 4°C overnight. Further digestion was performed the 
following day with collagenase (1500 units) in Leibovitz L-15 media. Cell suspensions 
were triturated, filtered, centrifuged and resuspended in culture medium. Culture medium 
was made following Hansen et al. [38] using DMEM F12 (Thermo Fisher Scientific, 
Waltham, MA), 10% equine serum (Thermo Fisher Scientific, Waltham, MA), 2% chick 
embryo extract (Gemini Bioproducts, West Sacramento, CA), 50 µg/mL human insulin 
(Sigma-Aldrich, St. Louis, MO), 2 mM L-glutamine (Thermo Fisher Scientific, Waltham, 
MA), 20 U/mL penicillin (MP Biomedicals, Solon, OH), 50 µg/mL streptomycin (MP 
Biomedicals, Solon, OH), 63 µg/mL tranexamic acid (Sigma-Aldrich, St. Louis, MO) and 
33 µg/mL aprotinin (Sigma-Aldrich, St. Louis, MO).  
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4.3.2 Sample Preparation and Culture 
Fibrin-based engineered tissue samples were fabricated using methods described 
by Hansen et al. [38]. Briefly, a reconstitution mixture was prepared on ice comprising of 
4.1 x 10
6
 cells/mL, 5 mg/mL bovine fibrinogen (Sigma-Aldrich, St. Louis, MO), and 100 
µL/mL Matrigel (BD Biosciences, San Jose, CA). For each sample, 485 µL of 
reconstitution mixture was mixed with 15 µL thrombin (100 U/mL, Sigma-Aldrich, St. 
Louis, MO) and transferred to a custom mold (Fig. 4.1). The custom mold was contained 
in a Petri-dish and consisted of a Delrin® (McMaster-Carr, Los Angeles, CA) housing 
and base each containing two neodymium magnets (Applied Magnets, Plano, TX), which 
allowed for easy coupling and uncoupling of the mold and base. The housing had a center 
channel 4.8 mm in width and 20 mm in length with 6.35 mm holes centered with the 
silicone posts and contained cylinder-shaped (1.6 mm diameter × 6.4 mm length) 
magnets. The base was 34 × 20 mm and contained disc-shaped (4.8 mm diameter × 1.6 
mm thick) magnets that aligned with the housing. Rectangular frames (34 × 12 mm) were 
cut from 0.30 mm thick polyester sheets (Mylar®, Fralock, Valencia, CA) using a cutting 
plotter (Graphtech FC7000, Irvine, CA) and AutoCAD (San Rafael, CA), and 
sandwiched between the housing and base. Frames had a rectangular center (10 × 4.8 
mm) and two 4 mm through holes spaced 26 mm apart (center-to-center). Silicone rods (2 
mm diameter x 7 mm length) were fabricated from a platinum cured silicone elastomer 
(VST-50, Factor II, Lakeside, AZ) and attached to either side of the frame window 
(spaced 12 mm center-to-center). The silicone posts served to suspend the fibrin-based 
gel (Fig. 4.1D). Samples were allowed to polymerize at 37°C for 90 min. After 30 min of 





Figure 4.1 – Sample preparation and bioreactor. (A) Exploded and (B) assembled view of 
mold for producing tissue samples. (C) Bioreactor comprised of two Petri-dishes and 




aid in removal of the mold from the tissue sample. The frame was cut on both sides and 
the sample was elongated by 40% and secured with nylon screws into a custom 
bioreactor comprised of two Petri-dishes outfitted with carbon rods spaced 2 cm apart for 
electrical stimulation (Fig. 4.1C) [39].  
Engineered tissue samples were precultured for 3 days before onset of electrical 
stimulation [22]. Following preculture, samples were subjected to electrical field 
stimulation (2 ms symmetric biphasic square pulses, 4 V/cm, 1 Hz) for 9 days. 
Nonstimulated samples served as controls for stimulated samples. Bright field images of 
central regions of the engineered tissue samples were obtained at days 3, 6, 9 and 12 of 
culture. The diameter was measured and the cross-sectional area was estimated assuming 
a cylindrical cross-section. The percent decrease in sample size was calculated 
normalized to the start of stimulation, i.e., day 3 of culture. At the end of culture samples 
were fixed with 4% paraformaldehyde and stored in PBS at 4°C.  
4.3.3 ET and MCR 
The excitation threshold (ET) and maximum capture rate (MCR) were measured 
at days 6, 9 and 12 of culture and for postnatal day 3 (P3) rat hearts following methods 
described previously [29, 33]. ET was defined as the minimum voltage required to elicit 
synchronous contractions over the entire sample and MCR as the maximum frequency for 
synchronous contractions at 150% of the ET. For engineered tissue samples, 
measurements were made following 30 min of media exchange. For P3 hearts, rats (n=4) 
were anesthetized with isofluorane inhalation. Following thoracotomy hearts were 
quickly excised and placed in a modified oxygenated Tyrode’s solution (in mM: 126 
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NaCl, 11 Dextrose, 0.1 CaCl2, 13.2 KCl, 1 MgCl2, 12.9 NaOH, 24 HEPES) at room 
temperature. Strips of left ventricular myocardium (≈2 × 2 × 4 mm) were excised and 
placed in the same bioreactors used for tissue culture. For all samples, ET was measured 
by applying square 2 ms monophasic pulses starting at 0 V/cm and incrementally 
increasing until the sample was observed to beat synchronously. MCR was measured by 
setting the voltage to 150% of the ET and increasing the frequency until the contractions 
became asynchronous, irregular or ceased.  
4.3.4 Native Tissue Preparation and Sectioning 
P12 and adult rat hearts were used for comparison to the engineered tissue 
samples. Tissue was processed as previously described [35]. Briefly, rats were 
anesthetized through methoxyflurane and hearts quickly removed. Hearts were perfused 
with a zero calcium Tyrode’s solution for 5 min followed by 2% paraformaldehyde for 15 
min for fixation using the retrograde Langendorff method [40]. Whole hearts and 
engineered tissue samples were stored in 30% sucrose in preparation for sectioning. For 
adult hearts, biopsies were obtained with a 5 mm diameter biopsy punch through the left 
ventricular wall. P12 hearts were maintained as whole hearts. Biopsied adult hearts, 
whole P12 hearts and engineered tissue samples were frozen in tissue freezing medium 
(Triangle Biomedical Sciences, Durham, NC) and sectioned using a cryostat (Leica 
CM1950, Wetzlar, Germany). Adult heart biopsies were sectioned parallel to the 
epicardial surface and P12 hearts from the top of the ventricles to approximately 2 mm 
from the apex to produce 80-100 µm thick sections. Longitudinal and transverse cross-
sections with a thickness of 100 µm were produced for engineered tissue samples. 
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4.3.5 Fluorescent Labeling 
Fluorescent labeling was performed before sectioning for engineered tissue and 
after sectioning for native tissue samples. Tissue samples were labeled as described 
previously [35]. Samples were either quad-labeled with wheat germ agglutinin (WGA) to 
identify cell borders, for α-sarcomeric actinin to identify myocytes, for Cx43 to identify 
gap junction channels and with 4’,6-Diamidino-2-phenylindole dihydrochloride (DAPI)  
to identify nuclei, or tri-labeled for α-sarcomeric actinin to identify myocytes, for 
vimentin to identify nonmyocytes (mostly fibroblasts) and with DAPI to identify nuclei.  
All labeling was performed on a laboratory platform rocker at room temperature 
(Thermo Fisher Scientific, Waltham, MA). Antibodies were diluted in blocking solution 
consisting of 4% goat serum (Invitrogen, Carlsbad, CA) and 0.5% Triton X-100 (Fisher 
Scientific, Pittsburgh, PA) diluted in PBS. Rinsing was performed between all incubation 
steps and included three 15 min rinses. For quad-labeling samples were incubated for 16 
h with WGA-conjugated CF488 (20-40 µg/mL in PBS, 29022, Biotium, Hayward, CA), 
16 h with mouse IgG1 anti-α-sarcomeric actinin (1:100, ab9465, Abcam, Cambridge, 
MA) followed by 6 h with goat anti-mouse IgG1-conjugated Alexa Fluor 633 (1:200, 
A21126, Invitrogen, Carlsbad, CA), 1 h with Image-iT® FX signal enhancer (Alexa 
Fluor 555 Goat Anti-Rabbit SFX Kit, A31630, Invitrogen, Carlsbad, CA) to block 
nonspecific antibody binding, 16 h with rabbit anti-GJA1 (1:100, SAB4300504, Sigma-
Aldrich, St. Louis, MO) followed by 6 h with goat anti-rabbit IgG-conjugated Alexa 
Fluor 555 (1:200, A31630, Invitrogen, Carlsbad, CA), and 3 h with 4’,6-Diamidino-2-
phenylindole dihydrochloride (DAPI) (1:500, Sigma-Aldrich, St. Louis, MO). For tri-
labeling samples were incubated for 16 h with mouse IgG1 anti-α-sarcomeric actinin 
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(1:100, ab9465, Abcam, Cambridge, MA) followed by 6 h with goat anti-mouse IgG1-
conjugated Alexa Fluor 633 (1:200, A21126, Invitrogen, Carlsbad, CA), 16 h with mouse 
monoclonal anti-vimentin-conjugated Cy3 (1:50, C9080, Sigma-Aldrich, St. Louis, MO) 
and 3 h with DAPI (1:500, Sigma-Aldrich, St. Louis, MO). Tissue samples were stored in 
PBS.  
4.3.6 Confocal Imaging 
Three-dimensional image stacks were acquired for samples labeled with WGA, α-
sarcomeric actinin, Cx43 and DAPI on a Zeiss LSM 5 Duo confocal microscope (Carl 
Zeiss, Jena, Germany) using a 40x oil-immersion objective lens with a numerical aperture 
of 1.3 [35]. Sectioned tissue samples were placed on a glass slide and surrounded by 15-
30 µL of Fluoromount-G™ Slide Mounting Medium (Electron Microscopy Sciences, 
Hatfield, PA). The tissue sample was covered with a coverslip (#0) and placed on the 
imaging stage. The x-axis of the image stack was aligned with the long-axis of the 
myocytes by visual inspection and adjustment of the scan direction. For engineered tissue 
samples, sections were briefly scanned using a 10x objective lens to locate dense regions 
of myocytes. Only regions with high cell density were imaged in this study.  
Image stacks were acquired with a spatial resolution of 200 × 200 × 200 nm and a 
typical field of view of 1024 × 768 × 200 voxels using a multitrack protocol for quasi-
simultaneous imaging of fluorophores in each 2D image slice. Laser lines with a 
wavelength of 364, 488, 543 and 633 nm were alternately applied to excite their 
associated fluorophores and collected using long pass 385 nm, band pass 505-555 nm, 
long pass 560 nm and band pass 630-650 nm filters, respectively. The dwell time was 
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typically 1.3-1.5 µs/pixel resulting in a total imaging time of approximately 1 h per image 
stack. Signal-to-noise ratio (SNR) of each image stack was measured as described 
previously [35]. Image stacks with a SNR below 3 were rejected. For whole sample 
examination of engineered tissue, 2D images were acquired using a 10x objective of 
central transverse and longitudinal tissue sections stained with α-sarcomeric actinin, 
vimentin and DAPI. Higher magnification (40x) 2D images were also acquired for 
engineered and native tissue samples stained with α-sarcomeric actinin, vimentin and 
DAPI.   
4.3.7 Image Processing  
Image stacks were processed to improve image quality as previously described 
[34, 35]. Briefly, image stacks were processed to remove background, correct for depth-
dependent attenuation and deconvolved using the iterative Richardson-Lucy algorithm 
with measured point spread functions. Cross-reactivity was corrected in image protocols 
where a primary antibody reacted with two secondary antibodies. The cross-reactivity 
was characterized by colocalization of Cy3 and α-sarcomeric actinin associated signal 
and removed by subtraction of Cy3-associated intensities.  Individual myocytes were 
segmented using a manual deformable triangle mesh fitted in three image planes (XY, 
XZ and YZ) using the WGA, α-sarcomeric actinin, Cx43 and DAPI image data [34, 35, 
41]. The manual segmentation was refined using the WGA image data. Principal 
component analysis was performed for each segmented myocyte to yield eigenvectors e1, 
e2 and e3. A bounding box was created for each segmented myocyte using the coordinate 
system spanned by the eigenvectors. Length, width and height were determined from the 
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dimensions of the bounding box. Myocyte volume was defined as the volume of voxels 
within the segmented myocyte and surface area was estimated from the surface area of 
the triangle mesh.    
4.3.8 Cx43 Analysis  
The percentage of the membrane stained positive with Cx43 was calculated for 
each segmented myocyte using projections of Cx43 intensities onto the myocyte surface. 
An illustration of this method is shown in Fig. 4.2. The membrane was approximated by 
surface voxels around the perimeter of the segmented myocyte. A 3D distance map was 
calculated from both the inside and outside of the membrane. Gradient vectors were 
calculated from the distance map. Cx43 intensities within 1 µm of the membrane were 
projected onto the membrane using the calculated distance map and vectors. The 
percentage of the membrane positive for Cx43 (MemCx43Pos) was calculated for each 
myocyte: 
            
            
     
 
 
with the number of membrane voxels (nvMem) and the number of membrane voxels with 
nonzero Cx43 intensity (nvMem,Cx43>0).  
The spatial distribution of Cx43 was characterized through projections of Cx43 
intensities on the eigenvectors of the myocyte [35]. Profiles were normalized with respect 
to total intensities and the range of arguments was transformed to [-1, 1] (i.e., centered 
with respect to the respective bounding box dimension). For each eigenvector, 





Figure 4.2 – Simplified schematic for calculating percentage of membrane positive for 
Cx43. Voxels are represented on a grid with blue indicating membrane and red indicating 
Cx43 staining. The integer values represent distance in voxels from the membrane. 
Gradient vectors were calculated from the distance map and Cx43 intensities were 
mapped to the membrane as shown in B.   
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of either end of the myocyte. The minimal polarization (Pol25%min), maximum 
polarization (Pol25%max), and the sum of Pol25%min and Pol25%max (Pol25%total) were reported. 
Uniform Cx43 distributions for a profile would lead to Pol25%total of 50%. Higher order 
statistical moments, skewness (γ1) and kurtosis (γ2), were calculated for the Cx43 
intensity profiles. Skewness and kurtosis are measures of asymmetry and peakedness, 
respectively. A skewness of zero indicates that intensities are evenly distributed on both 
sides of the mean, whereas positive and negative values of skewness indicate that 
intensities are concentrated in the negative (x<0) and positive (x>0) domain, respectively. 
The kurtosis of a normal or uniform distribution is 0 and -1.2, respectively.       
4.3.9 Myocyte Volume Fraction  
The myocyte volume fraction (MVF) was calculated by down-sampling the 
processed 3D image data for the α-sarcomeric actinin labeling. Original voxels with 
dimensions of 0.2 × 0.2 × 0.2 µm were resampled to 1.6 × 1.6 × 1.6 µm using the 
maximum value in a 26-voxel neighborhood relation [42]. This effectively “blurred” the 
sarcomeres and filled gaps between adjacent z-discs. Histograms of voxel intensities 
associated with actinin-positive regions were generated and thresholds were defined as 
mode intensity minus one standard deviation. Voxels above the threshold were 
considered actinin positive. MVF was defined as the sum of actinin positive voxels 
divided by the sum of all voxels within the image stack. 
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4.3.10 Statistical Analysis 
Data were reported as mean±standard deviations. Statistical significance was 
determined with a one-way ANOVA for each measure, followed by post-hoc Tukey-
Kramer tests with an α=0.05. Where appropriate, F-tests were performed to determine 
differences in variances with an α=0.05.  
 
4.4 Results 
4.4.1 Visual Inspection of Engineered Tissue Preparations 
Bright field images of the engineered tissue samples showed that samples 
progressively condensed during culture (Fig. 4.3). Engineered tissue sample cross-
sectional area estimated from the measured diameter was found to decrease to 17±3% 
and 16±5% for nonstimulated and stimulated samples at the end of culture from the onset 
of stimulation. No significant differences in cross-sectional area were observed between 
the nonstimulated and stimulated samples. Central transverse and longitudinal cross-
sections of whole tissue samples exhibited dense regions of aligned myocytes and 
fibroblasts (Fig. 4.4). Although nuclei appeared to be homogeneously distributed through 
the sample thickness, elongated myocytes were located approximately 200 µm from the 
sample periphery. Higher magnification confocal images showed that fibroblasts were in 
close spatial proximity to myocytes, however, P12 and adult native tissue samples 






Figure 4.3 – Engineered tissue size. (A) Images showing progression of engineered 
cardiac tissue size during culture (nonstimulated (n=9) and stimulated (n=12)). Scale bar 
1 mm. (B) Cross sectional area normalized to start of electrical stimulation (Day 3). Error 
bars denote standard deviation. Engineered cardiac tissue progressively decreases in 
volume as a function of time in culture; however, there is no statistically significant 





Figure 4.4 – Typical central confocal images of nonstimulated (A, C) and stimulated 
(B,D) engineered tissue stained with actinin (green) to identify myocytes, vimentin (red) 
to identify fibroblasts, and DAPI (blue) to identify nuclei. (A-B) Transverse and (C-D) 
longitudinal cross-sections. Dense regions of myocytes were found approximately 200 
µm from the periphery of the sample. Fibroblasts were found in close spatial proximity to 






Figure 4.5 – Typical confocal images of cardiac tissue samples stained with actinin 
(green) to identify myocytes, vimentin (red) to identify fibroblasts, and DAPI (blue) to 
identify nuclei. Engineered tissue from nonstimulated (A) and stimulated (B) samples 
cultured for 12 days. Left ventricular myocardium from P12 (C) and adult (D) rats. 
Myocytes and fibroblasts are in close spatial proximity. Visually, the stimulated sample 
(B) has more densely packed myocytes compared to the nonstimulated sample (A). P12 
and adult rat myocardium has densely packed myocytes and fibroblasts. Scale bar: (A) 50 




4.4.2 Functional Analysis 
ET and MCR were measured at days 6, 9 and 12 of culture and for isolated strips 
of P3 left ventricular myocardium. ET and MCR were not measurable at day 3 of culture 
as the samples did not respond to pacing. The ET decreased as a function of time in 
culture for both nonstimulated and stimulated samples, and the stimulated samples nearly 
approached the ET of P3 rat myocardium (Fig. 4.6). Stimulated samples had significantly 
lower ET at day 6 (2.79±0.15 vs. 3.85±0.29 V/cm), 9 (1.78±0.13 vs. 2.93±0.13 V/cm) 
and 12 (1.00±0.12 vs. 2.46±0.08 V/cm) of culture compared to nonstimulated samples 
(p<0.01). MCR increased as a function of time in culture for the stimulated group and 
exceeded that of P3 native myocardium by the end of culture (p<0.01). Nonstimulated 
samples exhibited an increase in MCR between days 6 and 9 (p<0.01), but not between 
days 9 and 12 (p>0.05). Furthermore, the stimulated samples had significantly higher 
MCR at days 6 (374±51 vs. 273±25 beats/min), 9 (569±40 vs. 379±33 beats/min) and 12 
(645±39 vs. 393±18 beats/min) of culture compared to nonstimulated samples (p<0.01).    
4.4.3 3D Confocal Imaging 
Three-dimensional confocal imaging and image analysis were applied to 9 
nonstimulated and 12 electrically stimulated engineered tissue constructs and 5 P12 
hearts and 7 adult hearts. The approach was applied to preparations stained with WGA, 
α-sarcomeric actinin, Cx43 and DAPI. Seventy-one image stacks from the 4 experimental 
groups were obtained. Image stacks with low SNR or motion artifact were removed for 
further analysis. Final data were obtained from 7 nonstimulated samples (n=11 image 





Figure 4.6 – (A) Excitation threshold and (B) maximum capture rate at Days 6, 9, and 12 
of culture and postnatal day 3 rat hearts. Excitation threshold progressively decreased and 
maximum capture rate progressively increased as a function of time in culture. * Denotes 
statistical difference in means determined by post-hoc Tukey-Kramer tests (α=0.05).  
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hearts (n=13 image stacks). Raw image data for engineered tissue samples are presented 
in Fig. 4.7. These stacks originate from ~1 µm outside the tissue surface and extend ~50 
µm into the tissue sample.   
  Processed image stacks from all groups confirmed that myocytes exhibited an 
elongated morphology (Figs. 4.8 and 4.9). Marked differences between the nonstimulated 
and stimulated samples were visually noticeable in the 3D image stacks. The stimulated 
group exhibited more densely packed myocytes with a more pronounced elongated 
morphology (Fig 4.8A, E), aligned sarcomeres in registry (Fig 4.8C, G), and more Cx43 
plaque formation on the myocyte membrane (Fig 4.8D, H). Marked differences between 
P12 and adult tissue were also apparent by visual observation (Fig. 4.9). P12 myocytes 
appeared smaller in size (Fig 4.9A, D) and had Cx43 plaque formation around the lateral 
sarcolemma (Fig 4.9D), whereas adult myocytes had Cx43 plaque formation primarily at 
cell ends (Fig. 4.9H). 
4.4.4 Myocyte Volume Fraction 
MVF was quantified by down-sampling the processed 3D image data for the α-
sarcomeric actinin labeling (Fig. 4.10). Down-sampling of the original images (Fig. 
4.10A-B) resulted in “blurring” of the actinin-associated intensities (Fig. 4.10C-D). 
Thresholding of the down-sampled images resulted in identification of the intracellular 
space of myocytes (Fig. 4.10E-F). The MVF was nearly double for the stimulated 
engineered tissue compared to nonstimulated (0.34±0.14 vs. 0.18±0.06, p<0.01). 





Figure 4.7 – Raw 3D image data of nonstimulated (A-D) and stimulated (E-H) 
engineered cardiac tissue. (A, E) DAPI, (B, F) WGA, (C, G) Cx43 and (D, H) α-










Figure 4.8 – Processed 3D image data of nonstimulated (A-D) and electrically stimulated 
(E-H) engineered cardiac tissue. (A, E) DAPI (blue), α-sarcomeric actinin (green) and 
Cx43 (red). (B, F) DAPI (blue), WGA (green) and Cx43 (red). (C, D, G, H) Zoomed 
region of (A, B, E, F, respectively) indicated by box. Scale bar: (A) 50 µm also applies to 





Figure 4.9 – Processed 3D image data of P12 (A-D) and adult (E-H) native left 
ventricular cardiac tissue. (A, E) DAPI (blue), α-sarcomeric actinin (green) and Cx43 
(red). (B, F) DAPI (blue), WGA (green) and Cx43 (red). (C, D, G, H) Zoomed region of 
(A, B, E, F, respectively) indicated by box. Scale bar: (A) 50 µm also applies to B, E and 






Figure 4.10 – Calculating myocyte volume fraction (MVF) in 3D image stacks. Actinin 
labeling (A, B) is resampled at 1.6 µm resolution (C, D) and thresholded (E, F) to 
estimate MVF. Nonstimulated (A, C, E) and stimulated (B, D, F). Scale bar: (A) 50 µm 





engineered tissue was significantly lower than that of P12 (0.90±0.06) and adult 
(0.91±0.04) myocardium (p<0.01).  
4.4.5 Myocyte Segmentation and Cx43 Analysis 
Myocyte geometry was quantified through segmentation of individual cells from 
the 3D image stacks. The segmentation process is shown in Fig. 4.11 with example 
myocytes from the four experimental groups. Manual manipulation of 3D triangle meshes 
and thresholding of the WGA channel were used to create 3D reconstructions of 
myocytes. Central cross-sections of the reconstructed myocytes (Figs. 4.11A, D, G and J) 
served for masking the WGA and Cx43 image data (Figs. 4.11B, E, H and K). 3D 
visualizations of the segmented myocytes and associated Cx43 labeling are shown in 
Figs. 4.11C, F, I and L.  Myocyte geometry was calculated from the segmented cells (Fig. 
4.12). Adult myocytes were significantly larger in length, width, height, surface area and 
volume compared to nonstimulated and stimulated engineered tissue and P12 native rat 
myocardium. Length, width, height, surface area and volume were not statistically 
different between myocytes from electrically stimulated tissue samples and P12 native 
myocardium. However, nonstimulated myocytes had more often a rounded morphology 
as indicated by a smaller mean length compared to stimulated and P12 myocytes and 
higher widths and heights compared to stimulated myocytes.    
The spatial distribution of Cx43 was characterized through projections of Cx43 
intensities on myocyte eigenvectors e1, e2 and e3 and measures of polarization and higher-
order statistical moments. Fig. 4.13 shows the profile projections for the segmented 






Figure 4.11 – Myocyte segmentation and visualization. (A-C) Nonstimulated, (D-F) 
stimulated, (G-I) P12 rat and (J-L) adult rat. (A, D, G, J) Central XZ-section of 
segmented myocyte (white) from image stack. (B, E, H, K) Corresponding central XZ-
section of image stack with WGA (blue) and Cx43 (red). (C, F, I, L) 3D visualization of 








Figure 4.12 – Myocyte geometry and volume fraction. (A) Table showing mean ± 
standard deviation. (B) Graphical representation of data from (A). Statistical difference in 












Figure 4.13 – Cx43 intensity profiles from cells in Fig. 4.11. (A-D) Nonstimulated, (E-H) 
stimulated, (I-L) P12 rat and (M-P) adult rat. Profiles were produced by projection of 
Cx43 intensities on the principal axes e1 (A, E, I, M), e2 (B, F, J, N) and e3 (C, G, K, O). 




formation indicated by the low percent membrane positive for Cx43 (Fig. 4.13D), and a 
large plaque dominated the profiles as indicated by a sharp peak in the Cx43 projection 
profiles (Figs. 4.13A-C). The stimulated myocyte had the majority of Cx43 plaque 
formation on one end of the cell as can be seen in the profile on eigenvector e1 (Fig. 
4.13D) and the large difference between Pol25%e1min and Pol25%e1max and strong negative 
skewness (γ1e1) (Fig. 4.13H). The P12 myocyte had an approximately uniform 
distribution of Cx43 around the lateral membrane as can be seen in the profile for 
eigenvector e1 (Fig. 4.13I). The distribution had a skewness (γ1e1) near zero and a kurtosis 
near -1.2 which indicates a uniform distribution (Fig. 4.13L). Furthermore, the profile for 
eigenvector e3 (Fig. 4.13K) for the P12 myocyte showed a bimodal distribution, which 
indicates that Cx43 plaques were concentrated on the lateral sarcolemma as opposed to 
cell ends as seen in the adult myocyte. The adult myocyte had the majority of Cx43 
associated intensities at cell ends which can be seen from projections for eigenvector e1 
(Fig. 4.13M) and a Pol25%e1total greater than 50%. The Cx43 distribution was weakly 
asymmetric as indicated by a small difference in Pol25%e1min and Pol25%e1max and a small 
positive skewness (γ1e1). 
The extent of Cx43 plaque formation was assessed through calculating the 
percentage of membrane positive for Cx43 staining on segmented myocytes. 
Nonstimulated engineered tissue had a significantly lower percentage of the membrane 
area stained positive for Cx43 (3.5±3.4%) compared to stimulated engineered tissue 








Figure 4.14 – Percentage of membrane stained positive for Cx43. Statistical difference in 










Statistical results of Cx43 profiles for all segmented cells are presented in Fig. 
4.15. Myocytes from nonstimulated and stimulated engineered tissue and P12 native 
myocardium exhibited no polarization of Cx43, whereas adult myocytes had the majority 
of their Cx43 concentrated at cell ends (Fig. 4.15A). Nonstimulated myocytes had a large 
difference in Pol25%e1min and Pol25%e1max (Fig. 4.15A) and a high standard deviation of 
skewness (Fig. 4.15B) indicating that most cells had Cx43 plaques concentrated on one 
side of the myocyte. Furthermore, the measured skewness (Fig. 4.15B, E, H) and kurtosis 
(Fig. 4.15C, F, I) was highly variable for the nonstimulated group compared to all other 
groups for all three eigenvector profiles.         
4.5 Discussion 
In this study we applied 3D confocal imaging and analysis to test the hypothesis 
that environmental cues direct engineered tissue towards a phenotype resembling that of 
age-matched native myocardium. We characterized effects of electrical stimulation on 
myocyte geometry and the spatial distribution of Cx43 in engineered cardiac tissue, and 
applied the same techniques for characterization to age-matched and adult native tissue. 
The results of the study support the hypothesis that electrical stimulation directs 
engineered cardiac tissue towards a phenotype resembling that of age-matched native 
myocardium. Adult myocytes were found to have significantly different geometries and 
Cx43 distributions compared to both engineered tissue constructs and P12 myocardium 
(Figs. 4.12, 4.14, and 4.15). This suggests that age-matched native tissue serves as a more 
realistic target for both analytical comparison and development of design specifications 





Figure 4.15 – Quantitative results of Cx43 analysis. Polarization (Pol25%) (A, D, G), 
skewness (B, E, H) and kurtosis (C, F, I) for principal axes e1 (A-C), e2 (D-F) and e3 (G-
I). Statistical difference in means of total Cx43 polarization (Pol25%) (A, D, G) 
determined by post-hoc Tukey-Kramer tests (α=0.05) and variance of skewness (B, E, H) 










Although other studies have elucidated some of the effects of electrical 
stimulation on the development of engineered cardiac tissue [22, 28, 29]. A novelty of 
our study is in the comprehensive 3D imaging and analysis approach and quantitative 
comparison to native tissue. A key feature of the approach is the ability to extract 
individual myocytes from the image data and assign a reliable coordinate system from 
which measures of geometry and Cx43 are computed. The common approach of 2D 
imaging produces a single cross-section through a cell, which increases the chances of 
misinterpreting or overlooking data and introducing variability.  
The approach for fabricating tissue samples was based on methods described by 
Hansen et al. [38] and selected because of its success in producing tissue samples with 
densely packed, aligned myocytes. Both nonstimulated and stimulated engineered tissue 
samples showed dense regions of myocytes and fibroblasts, the two most abundant cell 
types in the heart (Fig. 4.4). Our observations of tissue sample development are in 
agreement with Hansen et al. [38]. Samples condensed to approximately 20% of their 
initial cross-sectional area (Fig. 4.3), and this process was independent of electrical 
stimulation. Cells appeared to have a rounded morphology and be homogeneously 
distributed through the sample at the beginning of culture. After 3-6 days in culture cells 
began to elongate, align and contract in isolated regions of the sample.  Contracting 
regions increased in size between 6-9 days of culture and whole samples were 
macroscopically observed to contract by the end of culture (day 12).  
In this study, electrical stimulation had a high impact on MVF. Although the 
MVF for the electrically stimulated group was less than half of that of P12 and adult 
myocardium, it was nearly double compared to nonstimulated samples. We suggest that 
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the increase in MVF in the electrically stimulated group is caused by more myocytes 
developing and maturing. This notion is supported by the fact that both the nonstimulated 
and stimulated samples started with the same number of cells, construct sizes were not 
statistically different at the end of culture (Fig. 4.3), and myocytes did not differ in 
volume (Fig. 4.12).    
Myocytes subjected to electrical stimulation had geometries and Cx43 
distributions which more closely matched P12 myocardium compared to nonstimulated 
myocytes and native adult myocytes. Under electrical stimulation myocytes were found 
to assume an elongated morphology as opposed to their nonstimulated counterparts, 
which often had a rounded morphology. This is consistent with previous studies [22]. 
Furthermore, sarcomeres were often disorganized in nonstimulated myocytes (Fig. 4.8C) 
compared to stimulated samples, P12 and adult tissue (Fig. 4.8G and Fig 4.9C, G, 
respectively). Moreover, electrical stimulation was found to increase the percentage of 
membrane positive for Cx43 plaques compared to nonstimulated samples (Fig 4.14). In 
fact, the percentage of membrane positive for Cx43 in the electrically stimulated group 
was not statistically different from P12 or adult rat myocardium.  
Previous studies have reported the spatiotemporal dynamics of Cx43 in postnatal 
development of rat [18] and human cardiac tissue [19]. In neonatal rat cardiac tissue, 
Cx43 plaques were found to be uniformly distributed over the myocyte membrane and 
remodeled to become concentrated at cell ends (i.e., polarization) at approximately 90 
days. In adult rat myocytes, Cx43 is mostly located at cell ends which was found in our 
previous [35] and other studies [15, 43]. Thus, our findings in this study are in agreement 
as P12 myocytes had no preference for Cx43 plaques at cell ends (Pol25%=40±9%) 
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compared to adult myocytes which showed the majority of Cx43 plaques were found at 
cell ends (Pol25%=63±13%). Myocytes from both engineered tissue groups were similar to 
P12 myocytes and had no significant Cx43 polarization. Cx43 profiles showed that 
myocytes from all groups had significant variability with respect to symmetry and 
polarization. Projections of Cx43 intensities on eigenvector e1 indicated that the 
nonstimulated myocytes had the largest difference between Pol25%min and Pol25%max, 
which was reflected in the large standard deviation of the skewness. Projections on 
eigenvectors e2 and e3 showed that the P12 myocytes had significant polarization 
indicating that Cx43 plaques were located along the lateral sarcolemma as opposed to 
centralized regions of cell ends as in adult tissue. The nonstimulated myocytes had the 
highest standard deviation in both measures of skewness and kurtosis for intensity 
profiles on all axes, suggesting high variability with respect to Cx43 distributions.  
Functional measures of ET and MCR were found to be influenced by electrical 
stimulation (Fig. 4.6). The lower ET and higher MCR found in the electrically stimulated 
group are in agreement with other studies which have applied electrical stimulation [22, 
29, 33]. The measured ET of 0.63±0.05 V/cm and MCR of 541±75 beats/min for P3 
neonatal ventricles measured in this study were in close agreement with other studies 
which ranged from 0.74±0.2 to 1.6±0.1 V/cm for ET and 413±7 to 475±25 beats/min for 
MCR [33, 44].  
4.5.1 Applications of Developed Approaches 
An application of the developed approach is to define specifications for tissue 
engineering. Specifications are paramount to the engineering paradigm and tissue 
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engineering is no exception. In this study, specifications were derived from normal age-
matched and adult left ventricular myocardium of rat since a central goal of tissue 
engineering is reestablishing features of the native myocardium. However, specifications 
can be derived for any requirement, for example, diseased cardiac tissue where the focus 
may be to understand the effects of pharmaceutical agents [1, 38]. 
Another application of the imaging approach and analysis is to characterize 
structural features of stem cell-based engineered tissue samples. Induced pluripotent 
human stem cells have the potential to differentiate into any cell type [45, 46], and have 
been specifically differentiated to cardiomyocytes [47]. However, their application in 
developing 3D tissue constructs is in its infancy [48].  
The imaging approach can also be applied to characterize other structural features 
of cardiac tissue. Sarcomeric actinin staining revealed that many myocytes in the 
nonstimulated group had sarcomeres that appeared to be disorganized compared to the 
stimulated, P12 and adult myocytes, which had well defined sarcomeres in registry. 
Fibroblasts, the majority of cells in the heart, play an important role in normal cardiac 
function such as maintaining the extracellular matrix, paracrine signaling, and cell-cell 
communication with myocytes and other fibroblasts [7, 8, 49]. Quantifying sarcomere 
organization and the spatial relationship of myocytes and fibroblast is of interest for 
future studies. Furthermore, measurements of function could be used in conjunction with 
the structural features quantified in this study to elucidate the complex structure-function 
relationships found in cardiac tissue. Moreover, the application of other environmental 
conditions, such as the combinational effects of electrical and mechanical stimulation, is 




Limitations relating to the preparation of native cardiac tissue are described in our 
previous study [35]. Our approach for structural characterization did not determine if the 
Cx43 labeling resulted in functional gap junctions. Assessment of phosphorylation [50] 
and colocalization with N-cadherin [51, 52] can offer insight into the potential 
functionality, but were not performed in this study. Furthermore, the total Cx43 
expression was not quantified in this study. Instead measures of the percent membrane 
positive for Cx43 were characterized, which can serve as indirect measure Cx43 
expression. Furthermore, the phenotype of the fibroblasts found in our engineered tissue 
constructs was not characterized. Fibroblasts can differentiate into myofibroblasts in 
culture, and the myofibroblastic phenotype can be present in injured myocardium [53]. 
Myofibroblasts are responsible for remodeling the ECM and paracrine signaling, 
however, their effects on engineered tissue have not been studied [54].  
Functional analyses were limited to measures of ET and MCR. Although these 
measures are well established in the field [22, 29, 33], other functional measures of, for 
instance, electrical conduction and excitation-contraction coupling, would be beneficial 
for comprehensive assessment of tissue constructs. However, the focus of this study was 
on characterizing structure through 3D confocal imaging and not on functional analyses. 
Measures of cardiac structure are not limited to myocyte geometry and Cx43 
distributions. However, those were selected because they are known to influence 
functional properties and undergo significant changes during development and diseased 
states [11-13].  
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Some of our image data required cross-talk correction, which is an a posteriori 
method based on detailed investigation of signal intensities. Images co-stained with α-
sarcomeric actinin and vimentin exhibited cross-reactivity of vimentin secondary (Cy3) 
with α-sarcomeric actinin primary, i.e., actinin exhibited both Alexa Fluor 633 and Cy3 
fluorophores. The cross-reactivity is due to the same species and isotype (mouse IgG1) of 
the antibodies. Vimentin antibodies raised in different species do exist and were tried in 
this study (e.g. Anti-Vimentin, C-Terminal antibody produced in rabbit, Sigma-Aldrich, 
St. Louis, MO, SAB4503083), however, without success.    
The described method for myocyte segmentation requires 3D confocal imaging 
and manual manipulation of triangle meshes, both of which are inherently time 
consuming and tedious. Automated methods for image acquisition and myocyte 
segmentation are a possible solution to this issue and will be addressed in future work. A 
further limitation of the presented approach is related to the volume of imaged regions. 
Each image stack spans approximately 200 × 150 × 50 µm of the sample volume. To 
overcome the relatively small volume of the image stack, several image stacks were 
obtained and only regions dense with myocytes were imaged. Dense regions were 
identified by scanning the sample with a 10x objective lens.  
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SUMMARY, CONCLUSIONS, AND FUTURE WORK 
5.1 Summary and Conclusions 
In this research, an engineering approach was applied to develop and utilize tools 
and methods to produce engineered cardiac tissue, characterize both native and 
engineered cardiac tissue and test the hypothesis that the structure of age-matched native 
cardiac tissue serves as a representative control for engineered cardiac tissue. Three 
phases of research were conducted to address unmet needs in the field of cardiac tissue 
engineering.  
In Chapter 2, a framework based on confocal microscopy was developed and 
utilized to characterize the microstructure in living cardiac tissue. Our developed 
framework includes a method for local dye delivery to living cardiac tissue, confocal 
microscopy techniques and image processing tools for the 3D analysis of myocyte 
geometry and the extracellular space. The developed framework for image processing 
and analysis served as a foundation for the research performed in Chapter 4. An 
important perspective of the developed imaging approach and analysis is the future 
application to diagnosis and patient-specific modeling of cardiac tissue structure.  
In Chapter 3, a bioreactor capable of continuously monitoring force-displacement 
in engineered tissue was developed. Our bioreactor was designed with common cell 
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culture equipment and off the shelf and easily reproducible components. A full bill of 
materials and associated engineering drawings are available for our bioreactor. A novelty 
of the developed bioreactor is in the ability to nondestructively characterize tissue 
samples during development. Our ability to quickly design and implement custom 
bioreactors was key to the work described in Chapters 3 and 4. This capability comes at a 
low cost and high value due to using standard off the shelf cultureware as starting 
material. 
In Chapter 4, approaches for confocal imaging and image analysis were 
developed and applied to quantitatively describe features of the native myocardium, 
focusing on myocyte geometry and spatial distribution of a major gap junction protein 
Cx43, in both engineered tissue and native tissue. We addressed the hypothesis that the 
application of environmental cues directs engineered tissue towards a phenotype 
resembling that of age-matched native myocardium. The results of the study support this 
hypothesis and reveal that electrical stimulation produces tissue with myocyte geometries 
and the spatial distributions of Cx43 which more closely resemble age-matched native 
myocardium as opposed to mature adult tissue.  
5.2 Applications and Future Work 
The developed bioreactor and imaging techniques have applications in 
engineering and characterizing stem-cell based cardiac tissue constructs. Induced 
pluripotent stem cells have been developed from human origin and resemble many 
features of embryonic stem cells [1, 2]. Induced pluripotent stem cells have the potential 
to differentiate into any cell type [3, 4] and have been specifically differentiated to 
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cardiomyocytes [5]. Although reprogramming efficiency is low and costly [6], enriched 
populations of cardiac myocytes can be collected through cell sorting techniques by 
recently identified cell surface markers [7]. However, the application of induced 
pluripotent stem cells to developing 3D tissue constructs is in its infancy [8]. The ability 
of induced pluripotent stem cells to form structural hallmarks of the native myocardium 
can be characterized and analyzed through the 3D confocal imaging and analysis 
techniques developed in this body of work.  
An important perspective of the developed imaging approach and analysis is the 
application to diagnosis and patient-specific modeling of cardiac tissue structure. Fiber-
optics based confocal imaging systems are being applied clinically for cellular-level 
characterization and detection of neoplasms [9-12]. The combination of our developed 
dye delivery approach with fiber-optics based confocal imaging and clinical 
catheterization techniques are a step towards extracting patient-specific microstructural 
data of cardiac tissue. These data, as well as the quantitative features extracted from 
native myocardium in the presented studies, can serve as definitions and inputs for 
computational modeling and simulation of cardiac tissue. Image data have been used to 
develop models of both physical and physiological properties of cardiac tissue [13, 14]. 
The 3D reconstructions of Cx43 distributions, myocytes and extracellular space can serve 
as inputs for mono- or bidomain models of cardiac conduction [15, 16] and discrete 
multidomain models that currently use idealized geometry [17]. Most models describe 
tissue properties with lumped parameters, homogenization approaches and analytical 
descriptions of microstructure or 2D image data [13, 18-20]. More realistic model inputs 
may create better predictive tools for analysis of cardiac function. 
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The imaging and tissue engineering approaches developed in this work can also 
be applied to better understand cell therapy strategies to treat heart disease. Cell therapy 
has been in the clinical arena since early 2000 with most studies reporting little to no 
change in cardiac function despite higher levels of success in small animal models [21, 
22]. A key limitation of cell therapy is the lack of a mechanistic understanding of how the 
delivered cells improve cardiac function [23-25]. A better understanding of how the 
delivered cells improve function may aid in translating positive results found in small 
animal models to clinical application in human patients. In fact, a recent study reports on 
utilizing engineering cardiac tissue as a platform for studying the fate of undifferentiated 
embryonic stem cells [26]. This study along with others support the application that 
engineered cardiac tissue can serve as a substrate for studying disease progression and 
tissue development, therapeutic intervention, drug discovery and mechanisms of cell 
therapy [27-29]. 
The addition of mechanical [30-35] or electrical stimulation [36-38] has been 
shown to produce favorable structural features and functional performance of engineered 
cardiac tissue constructs. However, the application of both mechanical and electrical 
stimulation to engineered cardiac tissue has not been implemented. Although they have 
been applied independently, it is difficult to conclude if one is more beneficial or if the 
combination of both will outperform the application of just one. In one study, electrical 
stimulation was applied with the addition of verapamil, an L-type calcium channel 
blocker [36], and similar expression levels of Cx43 were maintained compared to the 
drug-free control. This result suggests that electrical stimulation, even without 
mechanical contraction, promotes formation of gap junction channels. Future work will 
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involve outfitting the developed bioreactor with electrical stimulation capabilities to 
enable the application of both mechanical and electrical stimulation and elucidate their 
combinational effects. 
The force-sensing capabilities of the bioreactor allow for nondestructive 
characterization of mechanical properties during tissue culture. In principle, the 
developed confocal imaging and analysis of living tissue developed in the first phase of 
this research could be applied for the nondestructive characterization of microstructure in 
engineered cardiac tissue. Current analyses of structure and function are commonly 
constrained to endpoint analyses [39]. The combination of nondestructive 
characterization techniques for mechanical properties and structure can be used to obtain 
immediate feedback of tissue response and possibly adjust the specific mechanical or 
electrical conditioning regime to guide tissue towards a specific phenotype. Although 
applying confocal imaging to living tissue while maintaining sterility and not damaging 
tissue samples is technically challenging, strategies towards this direction are of interest 
in future work. 
The approach for segmenting myocytes from 3D confocal images requires manual 
manipulation of triangle meshes. This is an inherently time consuming and tedious 
process. Automated methods for myocyte segmentation, such as region growing, are 
possible solutions to increase throughput for myocyte segmentation. Future work will 
involve developing algorithms and processing techniques to increase myocyte 
segmentation throughput. Finally, functional parameters such as the force of contraction, 
electrical conduction and excitation-contraction coupling in engineered tissue could be 
measured and compared to structural changes. The characterization of both structure and 
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function can be utilized to better understand and elucidate structure-function relationships 
in cardiac tissue. 
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